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An Assessment of Cognitive and Sensorimotor Deficits Associated with APPsw and
P301L Mouse Models of Alzheimer’s Disease
Marcos F. Garcia
ABSTRACT

Behavioral characterization of animal models for Alzheimer’s Disease is critical
for the development of potential therapeutics and treatments against the disease. While
there are several known animal models of AD, three current models--APPsw, P301L, and
APPsw+P301L--have not been well characterized, if at all. This study, therefore, aimed
to perform a full behavioral characterization of these three models in order to better
understand the impairments associated with each one. Between 5 and 8.5 months of age,
animals were behaviorally tested in a variety of sensorimotor, anxiety, and cognitive
tasks. The number of tau+ neurons in the forebrains of P301L mice was then compared to
their behavioral performance.
Results of this study indicate that retinal degeneration (rd) seriously impairs the
performance of mice in behavioral tasks. Animals that carry the homozygous allele of
this mutation must, therefore, be eliminated from any such study requiring visual acuity.
After this elimination, my findings indicate that APP mice are impaired in several
cognitive tasks (including platform recognition, Morris maze, Y- maze, and radial-arm
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water maze) at a young early age (5 to 8.5 months of age). These mice have fairly normal
sensorimotor function, showing significant impairment only in balance beam
performance starting at 5 months. Although P301L mutant Tau mice, as a group, did not
have significant impairments in any sensorimotor or cognitive task, correlation analysis
revealed that higher numbers of tau+ neurons in cortex and hippocampus were associated
with poorer cognitive performance. Finally, discriminant function analysis (DFA)
appears able to accurately discriminate between the three transgenic groups of mice using
only an 8-measure data set.
In conclusion, this study provides the first comprehensive, multiple task
behavioral assessment of the APPsw and P301L animal models of AD, indicating that
APPsw mice are cognitively impaired at an early age while P301L mice are largely
unimpaired through 8.5 months. Nonetheless, correlational analysis implicates the
formation of neurofibrillary tangles in the onset of cognitive impairments. Finally, my
findings recommend the continued use of DFA to determine if groups of animals, based
on different trans genicity or therapeutic treatment, could be discriminated between from
their behavior alone.
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Introduction
Alzheimer’s disease (AD) is widely considered to be the most prevalent form of
dementia, occurring primarily in mid to late- life. Statistics indicate that AD affects up to
10% of all individuals over the age of 65 and 40% of those over the age of 80. Overall,
AD accounts for approximately 81% of all cases of dementia. As life expectancies
continue to increase worldwide due to advances in medical treatment, the number of AD
cases is expected to rise dramatically over the next 50 years (Janus and Westaway, 2001).
Therefore, the development of therapeutics to combat AD and alleviate its symptoms is
becoming more critical with each passing year.
AD is characterized by progressive memory impairment, disordered cognitive
function, and a progressive decline in language function. The time-course for AD in
affected individuals can last between 2 to 20 years. Typically, the first symptoms related
to AD are moderate losses in working memory and language function accompanied by
mild depression. As the disease progresses, the deficits in working memory and language
function become more severe and long-term memory begins to be affected. Lastly, the
final stages of AD are characterized by a virtually complete loss of memory and intellect,
leaving the patient in a bedridden, vegetative state that ultimately results in death.
Researchers have already identified what many refer to as the two “pathological
hallmarks” of AD—the formation of neuritic plaques and neurofibrillary tangles. Neuritic
plaques are small patches composed of amyloid protein that sticks to neurons and attracts
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microglia as well as astrocytes. The formation of these plaques leads to neuronal death,
primarily in areas of the limbic and association cortices. Neurofibrillary tangles (NFT’s)
are created when tau, a normal, microtubule-associated protein found in most neurons,
becomes hyperphosphorylated to form paired helices that disrupt axonal conduction and,
ultimately, results in the death of the neuron. NFT’s can be found in the entorhinal cortex,
hippocampus, parahippocampal gyrus, amygdala, frontal, temporal, parietal, and occipital
association cortices of AD patients. While these two lesions represent the hallmark
pathologic characteristics of AD, neuritic plaques and NFT’s can occur independently of
each other in AD as well as in other, less common neurodegenerative diseases (Selkoe,
2001).

Amyloid Precursor Protein
As previously mentioned, neuritic plaques, one of the two hallmarks of AD
pathology, are composed primarily of amyloid protein that becomes deposited in the
brain. Specifically, it is β-amyloid, or Aβ, that is principally responsible for the formation
of these neuritic plaques. Aβ, a protein composed of either 40 or 42 amino acids is, itself,
synthesized from a much larger parent protein named amyloid precursor protein, APP.
APP is a protein comprised of 695-751 amino acids that is commonly found in the
membranes of neuronal cells throughout the brain and central nervous system (Selkoe,
2001). The APP protein contains three principal sites where proteolytic enzymatic
cleavage can take place that is critical to the ontogeny of AD. Cleavage by α-secretase at
amino acid 687 results in two harmless APP subunits, APPs-α and C83. Cleavage of APP
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at amino acids 671 and 711/713 by β-secretase and γ-secretase, respectively, results in the
release of the cytotoxic Aβ 40 and Aβ 42 peptides, which are deposited.
Generally, it is thought that Aβ 42 begins the process of plaque development by
forming loose aggregates (diffuse deposits). This complex later attracts Aβ 40 , forming a
much denser, more compact plaque (Selkoe, 2001). As Aβ is deposited and begins to
form fibrils, microglia, the brain’s phagocytic cells, are attracted to the plaque site and
become activated. These activated microglia, which carry receptors for Aβ, are thought to
assist in clearing Aβ from brain tissue (Yan et al., 1996; Ard et al., 1996). However,
activated microglia are a two-edged sword in that they also respond to Aβ-activated
complement by secreting toxic agents such as free radicals and harmful proteases.
(Rogers et al., 1992). Activated microglia also release cytokines, such as IL-1 and TGFβ, which serve to activate astrocytes and attract them to the locations of Aβ plaques.
These activated astrocytes then trigger the release of two inflammatory mediators,
Apolipoprotein E (ApoE) and anti-chymotrypsin (ACT). ACT, an acute-phase
inflammatory protein that is over-expressed in astrocytes that surround Aβ plaques, is
thought to promote further deposition of Aβ and formation of more mature plaques
through direct molecular interaction with Aβ (Nilsson et al., 2001). ApoE, a 299-amino
acid lipid transport protein, is also thought to play a role in AD pathogenesis by
mediating the conformational transition of Aβ into β-pleated sheets, which further
promotes deposition (Holtzman et al., 1999; Wisniewski et al., 1992).
Researchers have come to understand that, as people age, levels of deposited brain
Aβ increase, enhancing the risk of developing Alzheimer’s Disease. While this increase
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generally occurs in mid-life or later, some individuals experience an increase in Αβ at a
much earlier age, leading to onset of AD symptoms. While the mechanisms that lead to
this increase in brain Aβ are not fully understood and could involve age-related
reductions in Aβ breakdown or clearance from the brain, certain mutations have been
identified that are purported to enhance β-secretase and/or γ-secretase activity, increasing
the likelihood that Aβ will result in the brain. One such mutation occurs on the
presenilin-1 protein (PS-1) and has been thought to significantly increase the activity of
γ-secretase (Selkoe, 2001). While the exact mechanism of PS-1 action with regards to γsecretase has yet to be elucidated, two general theories have been developed to describe
its potential function. Some researchers have suggested that PS-1 is a direct co-factor of
γ-secretase and, thus, is required for the normal function of γ-secretase. This theory is
supported by experiments showing that PS-1 “knock-out” mice have deficient γ-secretase
function (De Strooper et al., 1998). The second theory is that PS-1, which serves as a
membrane-bound protein, may have a role in cell trafficking, controlling the interaction
of γ-secretase with its necessary cofactors. This theory is not widely supported (Naruse et
al., 1998). Also, point mutations on the APP protein near the β-secretase and γ-secretase
cleavage sites can alter the activity of these enzymes, resulting in greater Aβ 42 release
(Selkoe, 2001). Cases of AD in which a genetic mutation is to blame for an increase in
Aβ 42 release are referred to as familial AD, so called because it is inheritable through an
autosomic dominance process and is thus passed down through families. Familial AD
comprises only 10% of the known cases of AD in individuals. The majority of AD cases,
~90%, occur through unknown causes and are referred to as sporadic AD (Janus and
Westaway, 2001).
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Neurofibrillary Tangles
The second pathological hallmark of AD is the formation of neurofibrillary
tangles within the axons of affected neurons in the brain. These tangles are composed of a
protein named tau, which is norma lly bound to axon microtubules. When tau protein
becomes hyperphosphorylated by unknown kinases, it dissociates from the microtubule
and forms insoluble, paired, helical filaments. The formation of these paired, helical
filaments strangles the axon, eventually killing it and preventing any downstream
communication (Selkoe, 2001). Recently, it has been concluded that tangle formation can
be induced by Aβ−mediated phosphorylation of the tau protein, propagating the theory
that amyloid deposits and NFTs may act in concert to generate AD pathology (Götz et al.,
2001). In addition to AD, NFT formation has also been linked with other less common
neurodegenerative diseases such as frontal temporal lobe dementia, Kuf’s Disease, and
sclerosis panencephalitis (Selkoe, 2001).

Transgenic Mouse Models of Alzheimer’s Disease
In order to better understand the mechanisms underlying AD and test potential
therapeutics against the disease, transgenic mouse models are needed. Transgenic mouse
models are generated by inserting either wild-type or mutant AD transgenes into the
genome of a fertilized egg. Specific promoters, such as PDGF1-β (Games et al., 1995),
PrP (Hsaio et al., 1996), and thy-1 (Sturchtery-Pierrat et al., 1997), are used to ensure that
the desired mutation is expressed in the brain. When the litter is born, the progeny are
genetically screened to select only the mice that carry the mutation. In this way, we may
observe the effects of particular genes of interest in the pathophysiology of AD.
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One particular mutation that results in an increased release of toxic Aβ 42 is the
Swedish mutation (APPsw), so named because it was discovered in a large Swedish
family that suffers from familial AD. The APPsw mutation is a double point mutation
that occurs at amino acids 670 and 671 of the APP protein, where a lysine residue is
changed to asparagine and methionine is replaced by leuc ine, respectively. The APPsw
mouse model is generated using a hamster prior protein (PrP) promoter that expresses the
mutation in neurons of the brain. The combination of these two mutations on the APP
protein is thought to increase the activity of β-secretase, creating a greater likelihood that
Aβ 40 and Aβ 42 will be released (Selkoe, 2001).
In addition to the APPsw mutation, the V717F point mutation on the APP gene,
also called the PDAPP mutation, is known to cause an increase in Aβ 42 release.
Transgenic mice that carry this mutation over express a mutated human APP minigene
that is driven by the platelet-derived growth factor promotor. The result of this mutation
is increased γ-secretase activity, which leads to greater cleavage at the carboxy terminus
of the Aβ protein (Dodart et al., 2000).
As mentioned previously, mutations to the PS1 protein, which participates in the
γ-secretase complex, also result in a greater release of Aβ 42 , apparently by increasing the
activity of γ-secretase (Selkoe, 2001). Two such mutations, M146L or M146V, are
currently employed in transgenic mice, under control of the PDGF-β2 promotor. When
either of these PS-1 mutations are combined with the APPsw mutation in transgenic
mice, commonly called the PSAPP model, Aβ production is further enhanced (Duff et al.,
1996; Holcomb et al., 1998), resulting in enhanced and earlier Aβ deposition.
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Mutations to the tau protein can also promote AD pathology, notably NFT
formation intraneuronally. In addition to AD, NFT formation prominently found in
several other neurodegenerative disorders (collectively known as “tauopathies”):
progressive supranuclear palsy (PSP), corticobasal ganglionic degeneration (CBD), and
frontotemporal lobe dementia (FTD). FTD, the most common of these disorders, involves
impaired social conduct, diminished speech leading to muteness, and progressive
dementia in affected patients (Kwon, 2002). There are three such point mutations to the
tau protein that are commonly used in transgenic mouse models of AD: P301L controlled
by the mouse prion protein promotor (MoPrP), V337M, under the expression of the
PDGF-β promotor, and R406W, under control of the CaMK-II promotor. All of these
mutations are capable of generating NFT’s when overexpressed in transgenic mice. Each
of these models, however, differ in their temporal sequence and regional distribution of
NFT formation, as will be discussed later.
In the following pages, I will attempt to summarize the current literature
describing transgenic mice carrying these different mutations that produce Alzheimer’slike pathophysiology. In particular, I will be discussing the principle behavioral and
pathological findings from these studies in order to provide a reasonable assessment of
what is currently known in the field of Alzheimer’s transgenics with regard to these
mutations.

APPsw Model: Pathology and Brain Aβ levels
The first study to examine the APPsw mouse model of AD was authored by Hsaio
et al. (1996). In this study, the authors determined, through ELISA, that transgenic mice
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between 11 and 13 months of age have, on average, 5 times more Aβ 40 in their brains
than transgenic mice between the ages of 2 to 8 months. Likewise, the oldest group of
transgenic mice was also found to have 14 times more brain Aβ 42 than mice in the 2-8
month-old group. Of the three Tg+ mice in the 11 to 13 month-old age group that
underwent neurochemical analysis, all three were found to possess classic senile plaques,
including dense amyloid cores, as well as diffuse deposits of Aβ. These deposits were
limited to frontal, temporal, and entorhinal cortices, as well as the hippocampus,
presubiculum, subiculum, and cerebellum. The densest amyloid cores were found in the
cortex, subiculum, and presubiculum. Amyloid deposits were absent in all of the nontransgenic mice analyzed in this study, as well as APPsw mice in the 2-8 month age
range.
A study conducted by Irizarry et al. (1997) found that Tg2576 mice at 16 months of
age, bearing the APPsw mutation, possess extensive Aβ deposits in the molecular layer
of the hippocampus, the cortex, and the amygdala. Specifically, the authors determined
that the CA1 region of the hippocampus, dentate gyrus, cingulate cortex, and entorhinal
cortex possessed an average amyloid burden of between 3.6 to 8.5%, as determined
through an immunostain using the R1282 polyclonal antibody. As expected, none of the
non-transgenic subjects demonstrated any Aβ immunoreactivity. Despite these moderate
levels of Aβ in and around the hippocampus, the stud y concluded that Tg+ mice did not
differ significantly from Tg- test subjects in the number of neurons in the CA1 region of
the hippocampus. This finding is particularly interesting since the hippocampus
undergoes extensive neuronal loss in the course of human AD and is thought to be
associated with behavioral deficits in mice. These results suggest that behavioral deficits
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incurred by APPsw transgenic mice might be the result of APP overexpression or the
abundance of small Aβ assemblies, rather than hippocampal cell loss.
In a similar study, Calhoun et al. (1998) examined a group of 14-18 month-old
APP23 mice expressing the Swedish mutation, but with a different promotor from
Tg2576 mice. Like Irizarry et al. (1997), Calhoun et al. (1998) found that these mice
possessed a large number of deposited Aβ plaques in the neocortex and hippocampus.
According to the study, at least 90% of plaques contained dense, fibrillar amyloid cores,
similar to the kind found in human cases of AD. In addition, vascular amyloid was
detected, primarily in the meningeal, neocortical, and thalamic vessels. In contrast to the
Irizarry et al. (1997) study, however, Calhoun et al. (1998) found that Tg+ mice showed a
significant decrease in the number of CA1 neurons when compared to their Tgcounterparts. Specifically, the study indicated that Tg+ mice exhibited a 14% reduction in
the number of CA1 neurons, with some animals possessing a particularly high plaque
load losing up to 25% of CA1 neurons. In general, the authors found that CA1 neuron
loss was directly proportional to Aβ plaque load. This finding challenges the observation
made by Irizarry (1997), stating that no appreciable CA1 neuronal loss is evident in Tg+
mice possessing a high Aβ plaque load. In the neocortex, however, Calhoun et al. (1998)
found no evidence of global neuronal loss and suggest that the neocortical neurons are
simply being physically displaced.
A study by Frautschy et al. (1998) examined a group of 10-16 month-old Tg2576
mice bearing the APPsw mutation to observe the relationship between plaque formation
and microglial activation. The study found that Tg+ animals possessed clusters of
microglia surrounding Aβ deposits, while Tg- animals had no such microglial clusters. In
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addition, it was observed that subjects containing small Aβ deposits showed only a few
or no activated microglia, while those who had larger Aβ deposits had greater amounts of
activated microglia. Further, the authors discovered that the Aβ 40 antibody was more
successful at staining activated microglia than the Aβ 42 antibody, suggesting that Aβ 40 ,
and not Aβ 42 , may be primarily responsible for initiating the microglial response in the
entorhinal and occipital cortex and the hippocampus. This theory is confirmed by
evidence obtained in previous studies indicating that, by 11-12 months of age (the
approximate time when microglia begin to show activation in the onset of AD), 60% of
Aβ plaques in Tg2576 mice are composed of Aβ 40 .
To identify the role of Aβ deposition in the formation of oxidative free radicals in
the brains of mice, Pappolla et al. (1998) studied groups of Tg2576 mice at 4 months and
21-25 months of age. These mice were sacrificed and immunostained for markers of
oxidative damage in the brain, specifically, CuZn superoxide dismutase (CuZnSOD) and
heme-oxygenase-1 (HO-1). In addition, the authors also stained for Aβ and ubiquitin,
using specific monoclonal antibodies. The authors found that, at 21-25 months of age, the
Tg+ mice displayed extensive signs of oxidative damage colocalized to regions of the
brain where Aβ plaques were found. Further, these regions of the brain with plaque
staining and oxidative markers were also found to stain for ubiquitin, an indicator of freeradical- mediated cytotoxicity. In contrast, 4 month-old Tg2576 mice showed no signs of
oxidative markers or Aβ plaques. Older Tg- mice, 21-27 months of age, likewise, failed
to demonstrate any Aβ plaques or oxidative markers. These findings promote the theory
that Aβ plaque deposition and free radical- induced cell death in the brain are temporally
linked. An in vitro cell culture study performed by Pappolla et al. (1998) further
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implicates Aβ in the formation of free radicals. In their experiment, the authors cultured
PC12 cells in the presence of Aβ 25-35 , and observed that these cells underwent rapid cell
death and demonstrated the presence of oxidative markers.
Benzing et al. (1999) examined a set of ten Tg2576 mice carrying the APPsw
mutation and found that they begin to show moderate amounts of Aβ deposits at 12
months of age and considerable deposition by 18 months. At the 18- month time point,
most of these deposits occurred in the temporal cortex, where plaques covered 24% of the
cortical surface area. Aβ plaques were also extensively found in the fronto-parietal lobe,
where 16% of the surface area was covered in plaques, and the hippocampus, which
demonstrated 10% surface coverage by plaques. Of the plaques found in the temporal and
fronto-parietal lobes, approximately 3% was found to be compact in nature, while about
6% of the hippocampal plaques were similarly constituted. Interestingly, at the 12- month
time point, the cortical surface coverage of Aβ plaques was considerably less, while the
relative percentage that is compact stayed the same.
Through the use of immunostaining, Benzing et al. (1999) also discovered that the
majority of fibrillar Aβ plaques in 12 and 18 month-old mice were closely accompanied
by activated microglia, the macrophages of the brain. These activated microglia were
found to contain IL-1β and TNFα, two immune cytokines. In addition, IL-6, another
immune cytokine, was found in activated astrocytes surrounding fibrillar Aβ plaques at
both the 12 and 18- month time point. These two findings, taken together, serve to
confirm the role of the neuroinflammatory processes in the pathogenesis of human AD.
Another set of Tg2576 mice with the APPsw mutation was studied by Mehlhorn
et al. (2000). In the study, the mice were shown to be free of fibrillar Aβ plaques in the
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hippocampus and cerebral cortex until approximately 14 months of age, despite
expressing the mutant APP mRNA as early as 2 months of age. Even at 14 months,
however, the Aβ plaque load is minimal. Immunostaining of the brains of these mice
revealed a large number of reactive astrocytes surrounding the newly developed fibrillar
Aβ plaques in the cerebral cortex at the 14- month time point. These astrocytes were
found to contain active forms of IL-1β and glial fibrillary acidic protein (GFAP), a
marker for astrocytes. Immunocytochemistry performed on sections of cerebral cortex at
the 12 and 13-month time points revealed no detectable IL-1β in Tg2576 mice,
suggesting that fibrillar Aβ deposition is required for astrocytes to become activated. In
addition, a multiple-probe ribonuclease protection assay performed on the frontal,
parietal, occipital, and entorhinal cortices of 2-13 month-old Tg2576 mice failed to detect
the induction of any pro- inflammatory cytokine mRNA, indicating the lack of any
inflammatory response prior to Aβ deposition. These two findings seem to indicate that
the deposition of Aβ and the formation of fibrillar Aβ plaques are needed to trigger the
release of pro- inflammatory cytokines and induce the activation of reactive astrocytes.
Kawarabayashi et al. (2001) indicates that the amount of detergent insoluble Aβ
shows a rapid increase in Tg2576 transgenic mice starting at around 6 months of age.
These levels of insoluble Aβ in the brain continue to increase rapidly from 6-10 months,
eventually leading to the formation of Aβ plaques by 9-12 months of age. Detergent
soluble Aβ is present throughout life.
In summary, the current literature indicates that mature Aβ plaques begin to form
in the cortex and hippocampus of Tg2576 as early 9-12 months of age. Aβ deposition
within plaques appears to cause the activation of astrocytes and microglia as well as the
12

concomitant release of inflammatory cytokines. While the direct role of Aβ in initiating
hippocampal cell death is still a point of contention, it appears that the rise in insoluble
levels of Aβ by 6-7 months is certainly implicated in the onset of several potentially
destructive changes in the brains of these transgenic mice, such as free radical formation
and initiation of the inflammatory response.

APPsw Model: Behavioral Findings
In the first study to assess the extent to which mice transgenic with the APPsw
mutation exhibit a loss of behavioral function, Hsaio et al. (1996) tested Tg+ and Tgmice in the Y-maze at 3 and 10 months of age, and the Morris Water Maze at 2, 6, and 910 months of age. The authors found that the Tg+ mice showed no behavioral deficits
compared to their Tg- counterparts up to 10 months of age. At 10 months, however, the
Tg+ mice were found to be impaired in their ability to spontaneously alternate between
the three arm choices in the Y- maze. Age- matched control mice demonstrated a
significantly greater percent alternation at the 10- month time point than their Tg+
counterparts. Arguably, however, Tg+ mice were already performing at chance levels at 3
months and, in that context, were impaired early in this task. 9-10 month-old mice also
showed impairment, compared to age- matched controls, in their ability to locate a
submerged platform in the Morris Water Maze task. The Tg+ mice required a
significantly greater amount of time to locate the hidden platform on each of the 6 days of
acquisition at 9-10 months, but not at earlier time points. With the hidden platform
removed following the 6-day spatial acquisition period, the mice were returned to the
pool, wherein their swim path was observed and recorded. It was determined that 9-10
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month-old Tg+ mice spent significantly less time in the target quadrant (which previously
held the platform) than their Tg- counterparts. However, Tg+ mice at 9-10 months did
not spend significantly less time in the target quadrant than younger Tg+ mice at 3 and 6
months. Nonetheless, these 9-10 month-old Tg+ mice made far fewer crossings over the
prior location of the hidden platform than their non-transgenic littermates. Some Tg2576
mice were later re-tested in the water maze, with spatial cues rearranged, at 12-15 months
of age. Once again, the Tg+ group continued to show significant impairment in both
escape latency and time spent in the goal quadrant when compared to Tg- mice, although
none of this data at 12-15 months was presented. As discussed previously, Hsaio et al.
(1996) found that these Tg2576 mice undergo a rapid increase in levels of Aβ 40 and Aβ 42
between 2-8 months and 11-13 months of age. Taken together, it appears that the
behavioral deficits demonstrated by these Tg2576 mice could be related to the increase in
brain Aβ levels/deposition.
A study conducted by Holcomb et al. (1998) focused on the differences between
APPsw single transgenic mice and APPsw/PS-1 doubly transgenic mice in behavior and
pathology. When Aβ load was compared between these two transgenic lines, the authors
discovered that the doubly transgenic mice experienced a significant increase (p<0.001)
in Aβ 42 and Aβ 40 from 6 weeks of age to 24-32 weeks of age while the APPsw mice
showed no significant change in the amount of either Aβ species through the same time
period. Consequently, by 24-32 weeks of age, the APPsw/PS-1 mice have a significantly
greater level (p<0.001) of Aβ 40 and Aβ42 than age-matched APPsw mice. This increase in
Aβ 42 for the APPsw/PS-1 mice began before the mice reached 12 weeks of age and was
followed by a second, more substantial increase in Aβ load between 12-16 weeks and 24-
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32 weeks of age. Testing in the Y- maze indicated that APPsw single transgenic mice and
APPsw/PS-1 doubly transgenic mice showed similarly lower percent alternations at 1214 weeks than either the PS-1 single transgenic group or the Tg- control group. These
findings seem to indicate that the APPsw mutation, and not the PS-1 mutation, is
primarily responsible for generating the Y- maze impairment. Also, it appears that this
impairment is unrelated to the formation of Aβ plaques, since the impairment at 12-14
weeks in APPsw mice occurs long before the onset of Aβ deposition in those mice. When
these same mice were compared for the number of arm entries made, APPsw/PS-1 mice
were found to have a significantly greater number of entries than any other transgenic
group. APPsw and PS-1 transgenic mice were not statistically different from Tg- mice in
their number of arm entries. Thus, it appears that the effect of the PS-1 mutation in AD
pathology is to increase the amount of Aβ 42 in the Alzheimer’s brain, inducing increased
exploratory behavior/activity prior to the formation of Aβ plaques.
In a follow- up to this study (Holcomb et al., 1999), the authors re-tested all four
genotypes of mice in the Y- maze at 6 months and 9 months of age. At the 6- month time
point, the APPsw/PS-1 and APPsw mice were each found to be impaired in percent
alternation compared to the PS-1 and Tg- groups. Only the APPsw/PS-1 mice were found
to have a significantly greater number of arm entries than Tg-, although the APPsw
groups showed a slightly elevated number of arm entries compared to Tg-. At 9 months,
only the APPsw/PS-1 group of mice demonstrated any impairment in the Y- maze for
either arm entries or percent alternation. These impairments are not progressive in nature,
however, since the APPsw and APP/PS-1 groups were already performing near chance
levels at 3 months of age. When tested in the Morris Water Maze at 6 or 9 months of age,
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no impairments were found in any of the transgenic mice for either acquisition or
memory retention. It is important to note, however, that the Tg- mice performed near
chance levels at 9 months and actually had a lower percent time in the platform quadrant
than the APPsw and APPsw/PS-1 groups. The authors failed to address this perplexing
finding. The conclusions from this study are similar to those reached in the previous
paper: the APPsw mutation is primarily responsible for the impairment in Y- maze
alternation while PS-1 serves to slightly enhance AD pathology (perhaps seen here
through the increase in the number of arm entries) by increasing the production of Aβ 42 .
None of the Y- maze behavioral changes seem to be related to Aβ deposition, as they predate the onset of plaque formation.
A study conducted by Westerman et al. (2002) creates a correlational link between
the onset of spatial acquisition deficits and the appearance of insoluble Aβ. In the study,
the authors tested four cohorts of animals bearing the APPsw mutation. These animals
were tested in the Morris Water Maze at various time points from 4 months of age to 25
months of age. Each animal received a total of 36 acquisition trials, with a probe trial
performed after each set of 12 acquisition trials to assess the amount of learning. Animals
with age-independent deficits were eliminated from analysis. The results indicate that,
prior to 6 months of age, the Tg2576 mice show no impairments in water maze escape
latency or probe trial when compared to their age-matched controls. Tg2576 mice tested
at 6-11 months, however, demonstrated lower mean probe trial scores, indicating that
they spent less time, on average, in the goal quadrant during memory retention trials than
their Tg- counterparts. Likewise, 12-18 month-old Tg+ and 20-25 month-old Tg+ mice
showed significantly lower MPS than their age-matched Tg- littermates. Tg- mice at all
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ages succeeded in scoring higher than chance in memory retention, such that the oldest
Tg- group was statistically not different from the youngest Tg- group. In the prior
acquisition phase of this task, 6-11 month-old Tg+ mice were normal compared to
control. However, 12-18 month-old Tg+ and 20-25 month-old Tg+ mice were impaired
in the last third of acquisition when compared to Tg-, demonstrating a significantly
greater latency to locate the hidden platform. Overall, none of the Tg+ mice were
impaired in acquisition when compared to their age- matched controls. These results were
even more meaningful when coupled with the fact that Aβ insol begins to appear in the
brains of Tg2576 mice at approximately 6 months of age. Less than 10% of the Tg2576
mice tested from the 4-5 month-old group contained Aβ insol while 70% of the 6 montholds and 100% of the 10 month-olds possessed Aβ insol. Detergent-soluble Aβ was present
in all the age groups of Tg2576 mice tested. These results seem to indicate, therefore, that
Aβ sol has little to no effect in the impairment of spatial memory while Aβ insol plays a
much larger role-perhaps through pathogenic Aβ oligomeric assemblies.
Westerman et al., (2002) also demonstrated that transgenic mice possessing both the
APPsw mutation and a mutant form of the PS1 mutation (APPsw/PS1) have a more
accelerated conversion of Aβ sol to Aβ insol. As a result, these “bigenic” mice begin to show
insoluble amyloid plaques by 3 months of age. Because these mice contain Aβ insol at an
earlier age than APPsw, APPsw/PS1 mutants showed more impaired performance in the
first probe trial than APPsw or PS1 single transgenic mice. Performance in the second
and third probe trials for the APPsw/PS1 mice was not significantly different than the
performance of the APPsw mice because of the steep learning curve associated with the
particular strain of mice used to breed these transgenes (FVB x 129). In summary, it

17

appears that small Aβ oligomers are mostly responsible for the disruption in water maze
spatial memory retention of Tg2576 mice (Westerman et al., 2002).
In addition to the APPsw mutation causing cognitive deficits, a study by Chapman
et al. (1999) illustrates that the APPsw mutation results in a loss of long-term potentiation
(LTP) in the hippocampus of affected mice. The authors tested this theory in vitro by
inducing LTPs in the dentate gyrus and CA1 region of the hippocampus in both Tg+ and
Tg- mice aged 2-8 months and 15-17 months. LTP induction was accomplished through
theta-burst stimulation to the Schaffer collaterals and the perforant pathway. For the 1517 month-old mice, the authors found that stimulus response in the CA1 and dentate
gyrus were significantly higher than baseline for the Tg- mice following tetanus but the
Tg+ mice demonstrated no significant increase in stimulus response. Mice in the 2-8
month-old group showed no impairments to LTP induction as both the Tg+ and Tg- mice
demonstrated increased response to stimulus following tetanus. Short-term facilitation
seemed unaffected in Tg+ mice, as response to the second stimulus in each pulse pair was
significantly higher than the first in all groups of mice tested. Tests performed on in vivo
mice confirmed the findings from the in vitro study since LTP induction was impaired in
APPsw mice at the 13-15 month time-point. When 16-17 month-old mice were observed
in the T- maze forced-choice alternation task, the study revealed that old APPsw mice
were significantly impaired compared to their age- matched controls in their ability to
learn the task. By contrast, 2 month-old APPsw mice learned the task as quickly as their
age- matched controls and quicker than the 16-17 month-old APPsw mice. Pathological
observations made after the LTP measurements and T- maze task indicate that the older
APPsw group of mice possessed high brain levels of Aβ, while their non-transgenic
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counterparts had none. Correlational analysis showed that impaired performance in the Tmaze is associated with loss of LTP induction.
In a similar study, Fitzjohn et al. (2001) tested a group of APPsw mutant mice and
determined that LTP induction is not impaired with age. In the study, the authors found
that in vitro CA1 synaptic transmission is, in fact, impaired in 12 month-old APPsw
mice. Despite this impairment, however, in vitro LTP induction was found to be normal
in the CA1 region of 12 and 18 month-old Tg+ mice using paired-pulse stimuli. Similar
results were obtained when examining the induction of LTP in the dentate gyrus of 18
month-old Tg+ mice. These findings seemingly contradict the results obtained by
Chapman et al. (1999). Fitzjohn et al. (2001) suggests that these disparate conclusions
could be explained by variations in basal synaptic transmission, possibly due to the use of
kynurenate, a fixative that has been shown to mask deficits in synaptic transmission.
A study by King and Arendash (2002a) sought to settle the disparities among the
behavioral literature involving Tg2576 mice by documenting the impairments of Tg+ and
Tg- mice in a full behavioral test battery at 4 distinct time points. Four groups of Tg2576
and Tg- control mice were put through a six week battery of cognitive and sensorimotor
tasks starting at 3, 9, 14, and 19 months of age, respectively. The authors found that Tg+
mice were more active in the open- field task at 3 months of age than their age- matched
controls. While Tg2576 mice were not more active in the Y- maze for any given time
point, the Tg+ mice did demonstrate a greater number of arm entries, overall, than nontransgenic mice. These two measures indicate that Tg2576 are more active and may show
less habituation to their environment. To assess sensorimotor performance, the Tg2576
mice were observed in the balance beam and string agility tasks. Data collected for the

19

Tg2576 mice indicate that these mice are unable to remain on the beam for as long as Tgmice at 3, 14, and 19 months of age. In general, a progressive decline in beam
performance was evident for both Tg+ and Tg- mice with increasing age. Similarly,
Tg2576 mice demonstrated inferior performance in the string agility task at 14 and 19
months when compared to Tg-. Likewise, string agility declined with age in both Tg+
and Tg- mice. These measures indicate that Tg2576 mice, in particular at older ages, are
far less agile and have less strength/agility than their Tg- counterparts. To elucidate any
cognitive impairment in Tg2576 mice, several tasks were used. The Y- maze, in addition
to indicating overall activity, can serve as a cognitive measure when percent alternation is
analyzed. When compared to age- matched controls, Tg2576 mice showed a lower
percent alternation (impaired performance) at 3 and 19 months of age, as well as overall.
Other cognitive tasks, includ ing circular platform, Morris water maze acquisition, and
Morris water maze retention, failed to demonstrate that the Tg+ mice were in any way
impaired, overall or at any specific age. The Tg2576 mice were, however, impaired
“overall” in the platform recognition task, as well as at 9, 14, and 19 months of age
compared to Tg-. Both groups of mice displayed a decline in performance with advancing
age. In the passive avoidance task, Tg2576 mice demonstrated a delayed latency to enter
the dark chamber in pre-shock testing at 14 months, perhaps indicating their lack of
exploratory behavior compared to Tg-. Surprisingly, Tg+ mice also displayed a greater
latency to enter the dark chamber during post-shock testing at 9 and 14 months of age,
perhaps due to greater fear/anxiety compared to Tg-. There was no transgenic effect,
however, in the active avoidance task. Finally, Tg2576 mice experienced a significantly
lower survivorship through 19 months than Tg-. Overall, it appears that, while Tg2576
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mice demonstrate significant sensorimotor deficits, they experience very little cognitive
impairment through 19 months of age. The nearly significant impairment at 19 months of
age for the Morris water maze acquisition indicates that cognitive impairment might
begin to occur beyond this time point. Another factor to consider is that the mice used in
this study were of the C57BL/6 strain, which possess a particularly high level of
intelligence, possible masking any transgene- induced impairments.
In a companion study to the one just described, Arendash and King (2002) sought to
determine what correlations exist between behavior performance measures in each of
their tasks for the Tg2576 mice carrying the APPsw mutation and non-Tg+ mice.
Determining the relationships between performances in different tasks could help us
identify the common features inherent in these tasks. In addition, understanding which
behavioral tests are correlated with one another could help us better assess the efficacy of
therapeutics and treatments against AD in transgenic mice. When the performances of all
169 mice were analyzed together, the authors found several correlations between
behavioral tasks. First, it was discovered that open- field activity and the number of Ymaze entries were highly correlated, underscoring the fact that both of these tasks assess
overall activity/exploratory behavior. In addition, balance beam performance and string
agility were also highly correlated, demonstrating the importance of balance and dexterity
in each of these tasks. All four of these tasks can be classified as sensorimotor measures.
When the authors looked at “intra-task” cognitive behavioral measures, they found that
performance in the water maze acquisition trials was highly correlated with memory
retention in the probe trial. Secondly, the number of errors made in the circular platform
task, where the mice are asked to locate a single escape hole among 16 that will lead
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them away from aversive stimuli, was found to be related to the overall escape latency. In
addition, a number of “inter-task” correlations were found between measures in various
cognitive tasks. For example, percent alternation in the Y- maze was found to be
negatively correlated with circular platform errors and latency, indicating that those
animals with better alternation ability in the Y-maze were quicker to locate the escape
hole in the circular platform. Platform recognition escape latency, not surprisingly, was
correlated with Morris Water Maze latency and circular platform latency, suggesting that
each of these tasks requires similar cognitive traits. Performance in platform recognition
was also determined to be inversely related to Y- maze alternation, indicating that the Ymaze is also cognitive in nature. Finally, there were several correlations discovered
between sensorimotor tasks and cognitive tasks. For example, open field activity and Ymaze entries were found to be inversely related to circular platform latency, indicating
that those animals that displayed higher activity in the open field and Y- maze were
quicker at escaping from the circular platform. In addition, balance beam performance
was determined to be inversely related to circular platform latency, demonstrating that
the circular platform task may have certain sensorimotor components to it. Platform
recognition latency, likewise, was found to have a negative correlation with balance beam
performance and string agility, suggesting that the platform recognition may also contain
some sensorimotor aspects. The implication of this data analysis is that performance in
one behavioral task can be highly predictive of performance in another task. What’s
more, these predictive correlations can be influenced by genetic background and age, as
many behavioral tasks were only correlated with one another when mice were divided
into groups of similar age and/or transgenicity. These results will go a long way towards
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better understanding how behavioral measures are related and how they can be classified
based on the skills they test.
In another stud y, King and Arendash (2002b) attempted to correlate synaptophysin
staining in the cortex and hippocampus of Tg2576 mice bearing the APPsw mutation
with behavioral impairments. In the study, the authors used a specific antibody to stain
for synaptophysin, a 38-kDa membrane glycoprotein that is localized to neuronal
synaptic vesicles. Previous reports involving various transgenic strains of mice have been
inconclusive concerning the precise relationship between synaptophysin staining, Aβ
plaque formation, and aging. The current belief is that increased amyloid levels/plaque
formation and the development of dystrophic neurites leads to a maintained area of
synaptophysin staining. In the present study, King and Arendash (2002) found that Tg+
mice retain their high levels of synaptophyin staining through time, presumably signaling
the formation of plaques, while Tg- mice begin to show a decline in staining as they get
older. Consequently, by the age of 19 months, the Tg2576 mice show a significantly
greater amount of synaptophysin staining than their Tg- counterparts, particularly in the
deep and outer layers of the neocortex as well as dentate gyrus, outer molecular layer and
polymorphic layer of the dentate gyrus in the hippocampus. This difference in staining
between the two genotypes could not be explained by tissue atrophy. For behavioral
analysis, the study employed 43 Tg2576 mice and Tg- controls divided into four age
groups: 3, 9, 14, and 19 months. The authors found that, for all animals combined, those
with greatest “cortical” synaptophysin staining demonstrated a heightened level of
activity, as determined through the open field activity and Y- maze entry tasks. These
animals were also observed to have difficulty in locating and swimming towards a visible
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platform in the water maze. Animals that possessed increased “hippocampal”
synaptophysin staining were found to have impaired performance in the balance beam
task as well as deficits in spatial acquisition and retention in the Morris Water Maze task.
When the 19 month-old animals were analyzed separately, high levels of cortical
synaptophysin staining correlated with increased open- field activity only. Synaptophysin
staining in the hippocampus of the 19 month-old mice correlated with impaired
performance in the balance beam, water maze, and platform recognition tasks. In
addition, the study found that, among 19 month-old animals, impaired performance in
water maze acquisition correlated with decreased hippocampal thickness and several
thinner hippocampal strata. These findings highlight the important interactions between
AD pathology and behavior in transgenic mice. The results of this study are consistent
with the hypothesis that maintained SYN-IR in brains of Tg2576 mice is associated with
impaired synaptic function and, consequently, cognitive deficits.
In summary, the behavioral findings described here indicate that APP
overexpression, and/or the process of Aβ deposition caused by the “Swedish” mutation to
the APP gene, induces deficits in cognitive and sensorimotor function in transgenic mice.
While the time course and extent of these deficits is still a point of contention, the current
evidence points to a direct link between an increase in the amount of insoluble Aβ
oligomers/amyloid plaques and the onset of AD- like behavioral abnormalities. The
existence of this link between pathology and behavior validates the APPsw transgenic
line as a valuable model for testing potential therapeutics against AD.
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Other Transgenic Models of Aβ Overproduction
Besides the APPsw mouse, there are other AD transgenic mouse models that
demonstrate an overproduction of Aβ. Among these models is the APPsw/PS-1 mouse,
often called the PSAPP model. This model possesses two mutations that enhance Aβ
production—the “Swedish” mutation, which increases β-secretase activity, and the
A246E PS-1 mutation, which increases γ cleavage of APP. When these two mutations are
combined, the result is a significant enhancement in the amount of Aβ generated in
affected neurons, as well as an earlier onset of AD-like pathology. Takeuchi et al. (2000)
found that PSAPP mice begin to display Aβ deposits in the neocortex, cingulate cortex,
and hippocampus as early as 3 months of age. These deposits were observed to increase
in size and density, encompassing the majority of the neuropil by 12 months of age. By
comparison, APPsw mice in this study did not form any plaques until 6 months of age,
becoming numerous only after 12 months. On average, PSAPP mice were found to
contain between 19 and 73 times more Aβ deposits than comparably aged APPsw mice.
Not surprisingly, PSAPP mice are found to demonstrate behavioral impairments as early
as 5 months of age. Arendash et al. (2001) discovered that PSAPP mice are more active
in Y- maze as early as 5 months of age. PSAPP mice are also impaired in the balance
beam task beginning at 5 months of age as well as the string agility task beginning at 15
months of age. PSAPP mice also demonstrate progressive impairments in Morris water
maze acquisition and radial-arm water maze working memory between 5-7 and 15-17
months of age. A follow-up study (Gordon et al., 2001), employing the same 15-17
month-old subjects, found an inverse correlation between Aβ (especially in compact Aβ
deposits) in the frontal cortex/hippocampus and radial-arm water maze memory. Inverse
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correlations were also found between compact Aβ loads in the frontal cortex and the
delayed retention trial of RAWM testing. These findings indicate that PSAPP mice
develop cognitive deficits in association with Aβ burdens.
Another transgenic mouse model that demonstrates an over expression of Aβ is
the APP V717F, or PDAPP model. The PDAPP model involves a point mutation on the
APP protein, near the γ-secretase cleavage site, that increases γ-secretase activity.
Behaviorally, an analysis of AD pathology described in a follow-up study (Dodart et al.,
2000) indicated that homozygous PDAPP mice begin to show Aβ deposits at 3-4 months
of age, while only half of all heterozygotes develop plaques at this age. Early plaques
were limited to the CA1 region of the hippocampus, medial cingulate cortex, and corpus
callosum. By 6-7 months of age, Tg+ mice start to develop plaques in the parietal and
perirhinal cortices. Finally, at 12 months of age, PDAPP mice demonstrate Aβ plaques in
the frontoparietal and temporal cortices, with homozygous Tg+ mice averaging 3 to 4
times more Aβ that age- matched heterozygous mice. Behaviorally, Dodart et al. (1999)
examined a set of PDAPP mice and determined that Tg+ mice begin to show
impairments in Radial-Arm water maze as early as 3 months of age, with homozygous
mutants demonstrating a more profound level of impairment at an early age. These
homozygous PDAPP mice also possess impairments in object recognition by 6 months of
age, while heterozygotes remain unimpaired through 9 months of age. All PDAPP mice
were shown to display greater locomotor activity from an early age. As an aside, the
authors noted that most of the PDAPP mice examined in this study suffered from
hippocampal atrophy and callosal agenesis from early adulthood onward---these two
conditions may further impair the cognitive performance of PDAPP transgenic mice.
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Tau Transgenic Models
As discussed in the introduction, the second major hallmark of AD is the
formation of intraneuronal neurofibrillary tangles (NFT’s). NFT’s are composed of the
microtubule-associated protein tau and their formation has been implicated in
neurodegenerative disorders such as progressive supranuclear palsy (PSP), corticobasal
ganglionic degeneration (CBD), and frontotemporal lobe dementia of the Parkinson’s
type (FTDP) (Kwon, 2002). Six unique isoforms of the tau protein exist in the adult
human brain, depending on how the tau mRNA is spliced from its gene, which is located
on human chromosome 17. These isoforms can be identified based on the presence or
absence of 29 or 58-amino acid inserts in the amino-terminal half of the tau protein and a
31-amino acid repeat region located in the carboxy-terminal half. Isoforms that contain
the 31-amino acid repeat are known as 4-repeat tau. Those isoforms that lack the 31amino acid are identified as 3-repeat tau (Kwon, 2002). NFT’s form when tau becomes
hyperphosphorylated and dissociates from the microtubule to form paired helices that
disrupt axonal conduc tion and, ultimately, results in the death of the neuron (Selkoe,
2001). At present time, there are three known mutations to the tau protein that result in
the production of NFT’s in transgenic mice: P301L, R406W, and V337M. The P301L
mutation only affects 4-repeat tau isoforms, while R406W and V337M affect all tau
isoforms. Each of these mutations involves changes to the microtubule binding repeat
region of the tau protein, which is thought to result in the partial loss of function of tau
and a reduced level of tau binding to the microtubules. Consequently, these mutations
markedly increase the tendency of tau filaments to aggregate, leading to the formation of
NFT’s (Kwon, 2002).
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Although not many studies have been performed dealing with mice transgenic for
the P301L mutation to tau, two important studies describe the pathology and motor
behavior associated with this mutation. In the first study, Lewis et al. (2000) observed a
group of JNPL3 mice carrying the P301L mutation. As early as 6.5 months of age, the
authors found that mutant P301L mice possessed neurofibrillary tangles in the
diencephalon, brain stem, cerebellar nuclei, and spinal cord. The authors also found “pretangles” and tau-positive processes in neurons of the cortex, hippocampus, and basal
ganglia. In addition, gliosis was observed in the spinal cord, brain stem, diencephalon,
and basal telencephalon of Tg+ mice, with up to a 48% loss of motor neurons in the
spinal cord. At 4.5 months of age, homozygous P301L mutants displayed a lack of escape
extension during tail elevation, spontaneous back paw clenching while standing, a
delayed righting response, and could only hold onto a string briefly before falling.
Hemizygous mice began experiencing these same behaviors at 6.5 months of age. In
addition, Tg+ mice demonstrated a reduction in grooming, weight loss, fewer
vocalizations, and increased eye irritation. These animals began to demonstrate hindlimb
paralysis by 8-10 months of age, with morbidity within 3-4 weeks thereafter. By contrast,
JN4 and JN25 mice, which do not express the P301L mutation at the same level as the
JNPL3 strain, failed to show any such impairment. Tg- controls, likewise, displayed
normal behavior. These findings, therefore, seem to correlate the formation of NFTs in
the brain and spinal cord with neuronal loss and sensorimotor abnormalities.
A study of mice bearing the V337M mutation to tau, a slightly less potent
mutation than P301L, showed that these animals also demonstrate behavioral
abnormalities (Tanemura et al., 2002). V337M mice at 11 months of age were found to
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have increased activity in the plus maze, spending most of their time in the open arms, as
well as increased activity in the open field. The V337M did not show any impairment in
the Morris Water Maze. Pathologically, these mice develop NFT’s by 10-14 months
within the hippocampus, as evidenced by irregularly shaped neurons, an accumulation of
RNA in the neuronal cytoplasm, and a lack of normal α-tubulin (indicating a loss of
microtubules). In addition, an ana lysis of neural activity in the hippocampi of V337M
mice, following an applied stimulus at the Schaeffer collaterals, indicated that Tg+ mice
generate a weaker depolarization response in the stratum pyramidale and stratum
radiatum. Because the P301L mutation leads to an early neuronal death in transgenic
mice, it is difficult to observe its pathology. Therefore, these pathological observations of
V337M mice are of special interest. The V337M mutation, unlike the P301L mutation,
does not lead to neuronal cell death in mice. Instead, V337M mutant mice develop
degenerative neurons, featuring atrophy of the nucleus and cytoplasm.
Tatebayashi et al. (2002) described the pathological changes and associative
memory deficits in Tg+ mice with another mutation to the tau protein, R406W. Like the
V337M model presented by Tanemura et al. (2002), this R406W mutation, under the
control of the CaMK-II promotor, is only expressed in areas of the forebrain, specifically
the hippocampus, neocortex, olfactory bulbs, striatum, and thalamus. According to the
authors, R406W mice begin to show NFT formation in these forebrain areas as early as
18 months of age. Tg- mice, accordingly, fail to demonstrate any abnormal tau pathology
at this same time point. The authors also report the presence of abnormally shaped
neurons in parts of the hippocampus, taking on a flame- like shape. These abnormal
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neurons were found to lack microtubules, but contained thin tau filaments, an observation
made previously by Lewis et al. (2000) in their study involving P301L mice.
To assess the physical impairments caused by expression of the R406W tau
mutation, the authors observed a group of 16-23 month-old Tg+ mice and their Tglittermates (at an age when Tg+ mice begin to show NFT formation) through a variety of
sensorimotor and learning tasks. The authors reported no significant transgenic effect in
any of the sensorimotor tasks; including acoustic startle response, accelerating rotarod,
and pole tests. The study did conclude, however, that Tg+ mice are deficient in certain
types of associative memory. The authors discovered that R406W mice are impaired in
contextual fear conditioning when tested 15 days after training, compared to Tg- controls.
Tg+ mice also showed deficiencies in cued fear conditioning when tested 48 hours after
receiving training. Tg- mice demonstrated a normal cued conditioning response
(Tatebayashi et al., 2002).
A second study conducted by Lewis et al. (2001) presented the pathology associated
with a group of transgenic mice bearing both the P301L tau mutation and the APPsw
mutation. These mice were generated by crossing a line of Tg2576 mice expressing the
APPsw mutation with a group of JNPL3 mice expressing the P301L tau mutation. The
authors were very curious to see if the presence of brain Aβ would have an effect on the
formation of NFTs, thus more closely simulating the conditions present in human AD
pathology. Lewis et al. (2001) found that the APPsw/P301L (TAPP) mice and APPsw
singly transgenic mice each possessed a similar number of Aβ plaques in the amygdala,
olfactory cortex, cingulated gyrus, entorhinal cortex, and hippocampus starting at 6
months of age. The P301L mutation, therefore, did not result in enhanced Aβ deposition.
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The TAPP mice, like the P301L singly transgenic mice, began to display NFT formation
in the spinal cord and pons as early as 3 months of age. The NFTs from the TAPP mice
and the P301L mice were identified as being morphologically similar to one another.
Interestingly, the authors found that older female TAPP mice, between the ages of 9-11
months, displayed up to 7 times more NFTs than the age- matched P301L female cohort,
primarily in olfactory cortex, entorhinal cortex, and amygdala. In addition, these female
TAPP mice displayed some NFTs in the subiculum, hippocampus, and the isocortex,
areas of the brain, where NFTs are rarely found in JNPL3 mice. In subcortical areas of
the brain, however, there was little difference in the concentration of NFTs between
female TAPP mice and P301L mice. The authors did note, however, that areas of the
brain with high concentrations of amyloid plaques failed to show a concomitant increase
in tangles. These results suggest that a high Aβ environment, and not the formation of Aβ
plaques, is directly responsible for the increase in the number of NFTs. Like the P301L
mice discussed earlier, these TAPP mice displayed similar motor disturbances and hind
limb paralysis with the same age of onset. The Tg2576 mice did not show any of these
impairments. In general, it appears that an interaction between Aβ (or possibly APP) and
tau is occurring in the brains of TAPP mice that is leading to an increased number of
NFTs and a similar level of sensorimotor and behavioral impairments as in tau mice.
Götz et al. (2001) performed a related study to better understand the relationship
between Aβ and tau. In this study, the authors injected synthetic Aβ 42 fibrils into the
sensory cortex and hippocampus of 5-6 month-old P301L mutant mice. A second group
of P301L mutant mice were injected with the reversed sequence of Aβ 42 to serve as a
control. Pathological comparisons between the test and control groups indicated that the
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mice injected with Aβ 42 had up to five times more NFTs in the amygdala than the
injection control P301L mice. A time-course analysis of the injected P301L mice
revealed that NFTs begin to form approximately 18 days following the injection of Aβ
fibrils and continue to increase in number unt il 60 days post- injection. Interestingly, the
authors noted that the formation of NFTs occurs remotely from the site of Aβ injection.
The rationale for this observation is that NFTs form in the cell bodies of neurons that
terminate at the Aβ deposition site. This theory is confirmed by the fact that the P301L
mice that received the Aβ injection demonstrated an increased amount of NFTs in the
amygdala, where most of the neurons whose axons terminate at the site of injection have
their cell bodies. Further, it appears that the induction of NFT formation by Aβ occurs
through the hyperphosphorylation of tau. Only the Aβ-injected mice showed any
reactivity to two antibodies that bind specifically to tau phospho-epitopes S422 and
S212/T214, respectively. This finding seems to indicate that Aβ induces a mechanism
that leads to the phosphorytion of tau at these two residues and the formation of abnormal
NFTs.
According to the conclusions of Götz et al. (2001) and Lewis et al. (2001), it
appears that the combination of Aβ 42 and mutant tau protein leads to an increased number
of neurofibrillary tangles in addition to the amyloid plaques present with the APPsw
mutation alone. Currently, the only mouse model that contains these two pathological
hallmarks of Alzheimer ’s disease is the TAPP mouse, which possesses both the APPsw
mutation as well as the P301L tau mutation. The creation of this mouse model is critical,
as its pathology seems to more closely approximate the characteristics of human AD than
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any other mouse model currently available. As such, the TAPP mouse model represents a
great potential for testing possible treatments and enhanced therapeutics against AD.

Retinal Degeneration
In the literature, it has often been reported that mice and other rodents are
sometimes known to suffer from a type of retinal degeneration that leads to near complete
blindness in affected individuals. This retinal degeneration is caused by an autosomal
recessive defect in the β-subunit of the rod-specific cGMP-PDE gene. The defect blocks
the phototransduction cascade, thus causing increased cGMP levels and ensuing
induction of Ca2+ channels to remain open (Ogilvie and Speck, 2002). This mutation,
often abbreviated as the rd mutation, leads to the rapid degeneration of rods within three
weeks after birth, eventually leading to the loss of cones, as well. While the mechanism
responsible for this retinal degeneration is not fully understood, it is thought that the
process involves a type of apoptotic cell death. (Ogilvie and Speck, 2002). Recently,
several studies have attempted to determine the extent to which retinal degeneration
might result in behavioral impairment. Spencer et al. (1995) performed such a study on a
group of aged, Sprague-Dawley rats with varying degrees of spontaneous retinal
degeneration. The authors found that those rats with the most severe retinal degeneration
performed significantly worse in the Morris water maze than those rats with less severe
retinal degeneration. Further, when the rats were re-tested in the Morris maze with the
platform placed in a new quadrant, the mice with more severe degeneration were unable
to learn the location of the new escape. Rats with less severe retinal damage were able to
learn the new location of the escape platform relatively quickly. In addition, severely
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degenerate rats spent far less time in the goal quadrant during a probe trial than less
degenerate rats. Likewise, Cook et al. (2001) determined that mouse strains carrying the
rd1 retinal degeneration gene display far less anxiety than rd- mouse strains when placed
in an elevated zero maze, preferring to spend more time in the open arms. In contrast, a
study performed by Fuller et al., (1973) indicates that rd/rd mice placed in a spatial water
T- maze are not significantly impaired in their ability to locate an escape ladder over a
period of 25 days of testing. The authors concede that visual cues play a negligible role in
this particular water maze, perhaps explaining why rd/rd mice fail to demonstrate an
impairment. Thus, it appears that retinal degeneration can have a significant effect on the
performance of mice and other rodents in behavioral tasks that require visual acuity.
Consequently, special attention must be placed on determining whether mice that are to
be behaviorally tested are homozygous for this mutation.

While the literature is fairly complete with regards to the behavior and pathology
of the APPsw mouse model, little is known about the behavioral impairments associated
with the P301L tau mutation. Even less is known about the pathology and behavioral
impairments associated with the Tau+APP model of AD. Given the importance of
creating the most ideal model with which to test potential treatments and therapeutics
against AD, it would seem vital to have a better understanding of how the behavioral
impairments of P301L or APPsw+P301L mice compare to that of the APPsw mouse. The
specific aims of my research, therefore, will be the following:
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•

Perform a full battery of sensorimotor and cognitive tests on a group of APPsw,
P301L, APPsw+P301L, and Tg- control mice, in order to compare the extent of
behavioral impairments associated with each of these three transgenic lines.

•

Determine the effect of the retinal degeneration gene on behavioral performance
across all four genotypes.

•

Elucidate any correlations between the number of tau positive neurons in the
brains of P301L mice and the extent of their behavioral impairment.

•

Test the ability of Discriminant Function Analysis (DFA) to distinguish the four
genotypes based on behavioral performance in test battery.

•

Use Factor Analysis (FA) to group behavioral measures that share common
factors.
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Methods
Animals
A total of 32 mice in four groups were behaviorally evaluated in this study: 7
mice carrying the “Swedish” APP double point mutations Lys 670 →Asn and Met671 →Leu
(APPsw), 10 mice possessing the Pro301 →Leu tau mutation (P301L), 4 mice expressing
both the P301L and APPsw mutations, and 11 non-transgenic control mice. The mice
were selected from the progeny of a cross between C57B6/SJL x SW/B6D2F mice
bearing the APPsw mutation and C57BL/DBA2 mice carrying the P301L mutation. All
subjects employed in the study were female. Several months prior to initiation of
behavioral testing, mice were individually housed in ALAC approved cages with access
to rodent chow and water under a 12- hour light/dark cycle. Animal care and use was in
accordance with the Guide and Use of Laboratory Animals, National Research Council,
1996, in a program and facilities fully accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care, International, under protocols approved by the
University of South Florida Institutional Animal Care and Use Committee (No. 1609,
David Morgan, PhD., Principal Investigator). Behavioral testing was performed only
during the day portion of the circadian cycle.
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General Protocol
At 5 months of age, animals were started in a 6-week behavioral test battery
(Arendash et al., 2001) to evaluate their sensorimotor abilities, anxiety levels, and
cognitive performance. A few noted tasks were repeated after the completion of the initial
test battery at the ages indicated. The following tasks were evaluated in the order
indicated and at, or beginning at, the age indicated:
Open field activity
Balance beam
String agility
Y-maze spontaneous alternation
Elevated plus-maze (anxiety)
17-measure neurologic screen
Morris maze (acq. & retent.)
Circular platform escape
Platform recognition
Radial-arm water maze
Visual cliff (visual acuity)

5M
5M, 6.5M, 8.5M
5M, 6.5M
5M, 8.5M
5M
5.5M
5.5M
6M
6M
6.5M
7M

Upon completion of behavioral testing, all animals were euthanized at 9 months
of age, wherein they were transcardially perfused with 25mL 0.9% saline according to
the procedure outlined in Gordon et al., (2002). Brains of the P301L mice were promptly
removed and the left hemispheres were immersion-fixed in freshly depolymerized 4%
paraformaldehyde (pH 7.4) for 24 hours. The hemispheres were then cryoprotected using
a series of sucrose solutions and later frozen and cut through the horizontal plane into
25µm sections using a sliding microtome and stored at 4o C in Dulbecco’s phosphatebuffered saline. Tau+ neurons were stained using an anti-phosphorylated tau primary
antibody, incubated at 4o C for 18 hrs. A biotinylated secondary antibody was added for
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120 min., followed by avidin-biotin-peroxidase complex, using the Vectastain Elite kit,
for 5 minutes. The Oncor V150 color image analysis system was used to quantify the
number of stained Tau+ neurons in the hippocampus, cortex, amygdala, brain stem, and
whole brains of the P301L mice. For each brain region, 4 to 16 horizontal sections were
stained and analyzed, spaced between 2000 and 3600µm ventral to bregma. The
measurement area for each region was a rectangular video field of 850,000µm2 . For each
region, the measurement area was carefully positioned such that the sections from each
mouse could be matched as closely as possible.
Genotyp ing for the rd gene, as well as the APP and Tau transgenes, was
performed using PCR of a DNA sample extracted from the tails of all experimental
subjects (Gordon, personal communication).

Specific Behavioral Testing Procedures
Open Field. To assess general levels of activity and exploratory behavior, each mouse
was placed in the center of a square (81 x 81cm) open black box with 28.5 cm walls and
lines painted on the floor to demarcate 16 squares (each 20 x 20cm). Each mouse was
allowed to roam freely for five minutes inside the box. The total number of lines crossed
during the 5- minute period was recorded.

Balance Beam. In order to evaluate balance and general motor function, each mouse was
tested on a 1.1-cm wide beam, suspended 45.7 cm above a padded surface and supported
by two columns, 50.8 cm apart. At either end of the beam was an attached 14 x 10.2 cm
escape platform. Each mouse was placed on the center of the beam in a perpendicular
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orientation and released for a period of up to 60 seconds. The total time spent by the
animal on the beam before falling (not to exceed 60 seconds) was recorded for each trial.
A total of three trials were performed in succession. If the animal was successful in
escaping onto the platform, a score of 60 seconds was recorded. The average score for the
three trials was calculated and recorded. This task, first done at 5 months, was repeated at
6.5 months and 8.5 months of age.

String Agility. To assess forepaw grip capacity and agility, animals were placed at the
center point of a tautly-suspended cotton string for a period of up to 60 seconds. The
string was suspended by the same two columns used in the balance beam task, 33cm
above a padded surface. Each animal was allowed to grasp the string with only its
forepaws, the n released for the 60 second trial. A rating system was used to quantify each
animal’s string agility: “0” if the animal is unable to hang onto the string for any length
of time, “1” if the animal hangs by its forepaws for 60 seconds, “2” if the animal makes
an attempt to pull itself up onto the string, “3” if the mouse places both forepaws and at
least one hindpaw on the string, “4” if the animal places all four paws and tail around the
string with some lateral movement, and “5” if the animal escapes to the support column.
The string agility score for each animal was recorded. This task was initially performed at
5 months and repeated at 6.5 months.

Y-maze. As a measure of general activity and basic mnemonic function, mice were tested
in a black Y- maze with three arms measuring 21 x 4 cm and surrounded by 40-cm walls.
Each mouse was placed into one of the three arms facing the middle area, and allowed to
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roam the maze for five minutes. The total number of arm entries and sequence of arm
entries were both observed and recorded for each mouse. Alternation, expressed in the
form of a percentage, was defined as the ratio of arm entries differing from the previous
two entries divided by the total number of entries. Thus, if an animal made the following
sequence of arm entries (3,2,1,2,3,2,1,3), the total number of alternation opportunities
would be six (total entries minus two) and the percent alternation would be 67%. Y- maze
performance was initially evaluated at 5 months, and then repeated at 8.5 months of age.

Elevated Plus Maze. To assess anxiety/emotionality, all animals were evaluated using a
plus-shaped maze elevated 82 cm above the floor. The maze consists of four arms, each
30 x 5 cm, including two opposite “closed” arms surrounded by dark walls and two
opposite “open” arms that are exposed without any walls. In the center of the maze is a 5
x 5cm common area. For the single trial given, each mouse was placed at the center of
the maze facing a closed arm, and allowed to freely explore the maze for a period of five
minutes. During this trial, the amount of time (in seconds) spent in the open arms was
observed and recorded, as well as the number of open arm choices and closed arm
choices.

17-Measure Neurological Screen. A comprehensive neurological screen, largely derived
from Irwin, (1966), was employed to further determine if any of the mice exhibited
sensorimotor impairments related to their genotype. All of the mice were initially
observed for transfer arousal, on a scale from 0 to 8 (with 0 = no activity) when moved
out of their home cage and into a novel environment. Each mouse was then assessed for
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the presence of an ataxic or hypotonic gait, as well as pelvic elevation, and tail elevation
on a subjective 0 to 8 scale, with 0 being normal. Each mouse was also presented with
two types of stimuli to assess their level of response. A cotton Q-tip was used to gently
rub the animal’s eye, in order to assess the mouse’s eye blink response, or corneal
opacity. The Q-tip was also used to gently poke the animal on its nose to quantify the
animal’s withdrawal reflex, as well as its tendency to approach the static Q-tip. A scale of
0 to 8 (8 = greatest response) was used for all three of these measures. The animal was
also presented with a loud “cricket” noise. A similar scale was used to quantify the extent
of the mouse’s response. In addition, each animal’s level of anxiety and activity in
response to being touched was assessed on a 0 to 8 scale. A wire mesh grid was
employed to test the mouse’s grip strength us ing its front paws. The mesh was also used
as a test of vision by evaluating at what point the mouse will reach out for the grid when
suspended by its tail and lowered to a grid just out of reach. Each mouse’s vision and
anxiety were also tested by assessing whether it would hesitate at the edge of a visual
cliff. Vision and anxiety were also evaluated in the elevated platform task, where the
animal is placed in the center of an elevated circular platform (21 cm in diameter) for a
period of 60 seconds. The latency to first head poke over the side, as well as the number
of times the mouse poked its head over the side of the platform was observed and
recorded. The mouse’s righting reflex was assessed by placing the animal in an empty
cage and gently shaking it while observing if the mouse is able to remain upright. This
observation was recorded as a simple yes or no answer. Finally, the toe pinch and tail
pinch tasks were administered to test the animal’s reflexes to painful stimuli.
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Morris Water Maze. To measure reference learning (acquisition) and memory
(retention), mice were placed into 100-cm circular pool filled with water at 22-27o C. The
pool was divided into four equal-sized quadrants with the use of two black lines drawn
along the bottom of the pool. The pool was surrounded by various visual cues, including
a halogen lamp, beach ball, colored wall poster, camera stand, as well as the
experimenter, which helped the mice to orient their location in the pool. A clear, 9-cm
platform was placed in the middle of quadrant II (QII), such that the surface of the
platform was exactly 1.5 cm below the water surface and visually indiscernible to the
mice. Reference learning (acquisition) occurred over a nine-day period with four
successive trials per day. On each trial, the animal was started from a different quadrant,
with the same quadrant start pattern taking place on each day of testing. The latency to
find the platform (up to 60 seconds) for each trial was recorded and a daily average
recorded for each animal. After locating the platform, the mouse was allowed to remain
on the platform for 30 seconds. If the animal failed to discover the location of the
platform in 60 seconds, it was guided to the platform and then allowed to stay for 30
seconds. A latency of 60 seconds would be entered into the record for such an
occurrence. On days 4, 7, and 10 (prior to acquisition testing, for days 4 and 7), each
mouse was administered a memory retention (probe) trial by allowing the animal to swim
in the pool for 60 seconds after the platform had been removed. Only one trial was
performed and the mouse was allowed to start swimming from a location just opposite to
the former platform quadrant. Each mouse’s retention trial was recorded on videotape
and the amount of time spent in each quadrant as well as average swim speed were later
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calculated and recorded. Mice were always allowed to dry under heat lamps before being
returned to their respective home cages.

Circular Platform. As a test of spatial learning/memory, each animal was observed in an
enclosed, 69-cm circular platform with 16 holes spaced 1.3 cm apart around the periphery
of the platform. A black curtain decorated with visual cues enclosed the platform. To
provide aversive stimuli that would motivate the test animals to escape the platform
surface, two 150-watt flood lamps were hung 76 cm above the surface of the platform
and a high-speed fan was mounted 15 cm above the platform surface Escape is only
possible through one of the 16 holes, where a box filled with bedding is placed
underneath the hole. The escape hole was changed for each animal, such that the same
animal would experience the same escape location for each day of testing, but different
mice would have different escape locations. Prior to actual testing, each mouse
underwent several “shaping” trials, wherein they were guided from the center of the
platform to their correct escape location. Following the shaping trials, animals were
tested for 8 days, with one trial per day. On each day, mice were placed in the center of
the platform, facing away from their respective escape hole, and allowed five minutes to
freely explore the platform. The total number of errors, defined as the number of times
the mouse poked its head through a non-escape hole, and the latency to find the escape
hole (up to 300 seconds) were recorded for each mouse.

Platform Recognition. To test for ability to recognize/locate a variably-placed visible
platform, each mouse was tested in the same pool used for the Morris Water Maze task.
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Instead of using a submerged, clear platform, however, the platform recognition task
employed a 9-cm circular platform raised 0.8 cm above the surface of the water with a
large 10 x 40 cm black and white ensign attached to the surface of the platform. The same
visual cues used in Morris Water Maze were again used in this task. Unlike the Morris
Water Maze task, however, all mice were started from the same location in the pool while
the platform was moved to a different one of the four quadrants for each trial. Each
mouse was tested for four days, with four trials per day. All four daily trials were
averaged for statistical analysis. For each trial, mice were allowed to swim freely for 60
seconds or until they located and ascended the platform. Upon reaching the platform, the
mice were given a 30 second stay. Mice who failed to reach the platform in the allotted
60 seconds were guided there and allowed to stay for 30 seconds. Following daily testing,
mice were allowed to dry under heat lamps before being returned to their respective home
cages.

Radial-Arm Water Maze. For assessment of working memory, each mouse was tested
in the same 100-cm inflatable pool used in the Morris maze and platform recognition
tasks, but with an aluminum frame insert added. This created six swim arms (30.5 cm
length x 19 cm width), radially distributed around the pool from a central circular swim
area of 40 cm in diameter. The aluminum walls stood approximately 5 cm above the
water surface. The same visual cues used in the Morris maze and platform recognition
tasks were again employed in this task. Each mouse was assessed in four successive
acquisition trials and one retention trial for each of the 12 days of testing. The last of the
four consecutive acquisition trials (T4) and the retention trial (T5) are an index of
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working memory. On each testing day, the same clear, submerged platform used for the
Morris water maze was placed at the end of one of the six swim arms. The platform
location was changed to different arms for each of the 12 days of testing in a semirandom pattern. The start arms for each of the four acquisition trials (T1-T4) and
retention trial (T5) were selected in a semi-random sequence from the remaining five
swim arms. For each acquisition trial, the mouse was placed at the end of the selected
start arm, facing the center of the pool. Each trial lasted one minute in duration, during
which the mouse was allowed to leave the start arm in search of the submerged escape
platform. An error was defined as each time the mouse swam into a non-goal arm or any
time the mouse swam into the goal arm without successfully locating the platform.
Following each recorded error, the mouse was returned (across the surface of the water)
to the appropriate start arm to continue the trial. Additionally, any animal that failed to
make an arm choice within 20 seconds of leaving the start arm was pulled back to the
appropriate start arm, assessed an error, and allowed to continue the trial. Each trial was
continued until the mouse located the platform or for a maximum of 60 seconds. Any
animal that failed to locate the platform in 60 seconds and made fewer than 3 choices was
assigned 3 errors for the purpose of statistical analysis. Upon reaching the platform, the
mouse was allowed to stay for 30 seconds before starting the next trial. If the mouse was
unsuccessful in locating the platform in 60 seconds, it was guided to the platform and
then allowed to stay for 30 seconds. For each of the four acquisition trials, the number of
error choices made prior to escape as well as the latency to locate the hidden platform,
were each recorded. Following the final acquisition trial (T4), the mouse were allowed to
dry under a heat lamp and then returned to its respective home cage for a 30-minute delay
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period. After 30 minutes, the mouse was returned to the pool for a single delayed
retention trial (T5). The same procedures as in the acquisition trials were followed and
the mouse was once again allowed to dry before being returned to its home cage.

Statistical Analysis
On the basis of genotypic analysis discussed earlier, the 32 test subjects were
divided into groups based on their transgene genotype (NT, APPsw, tau, or TAPP) as
well as their rd status (+/+, rd/+, or rd/rd). Table 1 indicates the number of test subjects in
each of these categories. Since rd/+ mice fail to show retinal degeneration, they were
grouped with +/+ mice for the purposes of statistical analysis. To determine the relative
effects of the rd gene and transgenicity on performance in each of the previously
described tasks, a two-way analysis of variance (ANOVA) was performed for each task,
using the Statistica analytical software package, with rd status and transgenicity as the
grouping variables. Following the ANOVA, post-hoc differences between groups (pairby-pair differences) were resolved using Fisher’s LSD test.
For statistical analysis of 28 selected behavioral measures for rd status and
genotypic effects, behavioral tasks were divided between those that were single day tasks
and those that involved multiple days of testing. The single day tasks (e.g.: open field,
balance beam, string agility, plus maze, Y- maze, and water maze retention) were
analyzed using a simple two-way ANOVA with the grouping variables described above.
The multi-day tasks (e.g.: Morris water maze, circular platform, platform recognition, and
radial-arm water maze) were analyzed using a simple two-way ANOVA as well as a twoway repeated measures ANOVA. Unless otherwise noted, all group differences were
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deemed significant at p < 0.05. For each task, animals defined as non-performers were
eliminated from further statistical analysis in that task.
Table 2 indicates the relative effects of retinal degeneration and genotype, as well
as the interaction between the two, on performance in each of the previously mentioned
tasks. Based on recent findings describing the effects of retinal degeneration on
behavioral performance (Spencer et al., 1995; Cook et al., 2001) as well as the statistical
analyses described in Table 2 showing rd/rd status impairs cognitive performance in a
number of tasks, it became necessary to remove all test subjects bearing the rd/rd
genotype from this study. As indicated by Table 1, the removal of all test subjects bearing
the rd/rd genotype left only one mouse carrying the TAPP double mutation. Since the
performance of this single TAPP mouse was comparable to the performance of the APP
group in all tasks except for circular platform and elevated plus maze, it was grouped
with the APP subjects for all tasks except for circular platform and elevated plus maze.
After the test subject pool was reduced in number following the removal of all
mice carrying the rd/rd gene, the data was re-analyzed in order to compare the
performance of NT (n=7), APPsw (n=4), and tau transgenics (n=7). Group differences
were calculated as described above, using transgenicity as the only grouping variable,
with the following differences. String agility was analyzed using the Kruskal-Wallis nonparametric test and Mann-Whitney U-Test, instead of ANOVA. In addition to the
measures previously discussed, all 19 sensorimotor battery tasks were analyzed using the
Kruskal-Wallis test and Mann-Whitney U-Test, with the exception of visual cliff, head
poke latency, and number of head pokes; these 3 measures were analyzed using ANOVA.
Further, all single day tasks that were performed repeatedly (balance beam, Y- maze, and
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water maze retention), were analyzed individually using ANOVA, then assessed with a
repeated measures ANOVA to identify progressive changes between the performance of
each group. In addition, an ANOVA was performed on the overall means for these tasks
to assess overall performance across the time frame in question. For all multi- trial tasks
(Morris water maze acquisition, circular platform, platform recognition, and RAWM),
group differences on the last day of testing were analyzed using ANOVA. Finally, swim
speed in the water maze retention task was determined using the Accuroute tracing
program and group differences analyzed via ANOVA. ANOVA was also used to analyze
quadrant preference within each group and percent time spent in quadrant 2 (the former
goal quadrant) across all groups.
In order to group behavioral measures by their common factors, all data was
evaluated through factor analysis using the Systat statistical software package. Factor
analysis works by considering all of the collected data, irrespective of transgenicity, and
grouping those measures into factors, each of which is measuring a different component
of behavior (i.e.: sensorimotor function, working memory, etc.). In this way, behavioral
measures related to one another might be determined, as well as how performance in one
task might be predictive of performance in another task. Two separate factor analyses
were run, each using a different grouping of the measures evaluated for all 18 test
subjects. The first analysis employed a comprehensive 39- measure dataset, while the
second analysis employed a more selective 19- measure subset of the behavioral data (see
Diagram 1).
To determine whether the 3 genotypic groups (NT, APP, and Tau) could be
distinguished from one another behaviorally, discriminant function analysis (DFA) was
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performed on both a 32 and 15- measure dataset (see Diagram 1), using the Systat
analytical software package. Circular platform and elevated plus maze measures were not
used in DFA analyses to avoid any conflicts from grouping the single TAPP mouse with
the APP group of mice in these two tasks (wherein the TAPP mouse’s performance was
appreciably different from that of
the APP mice.) Two unique DFA
analytical methods were
employed in this study, direct
entry method and stepwiseforward method. The direct entry
method utilized all behavioral
measures in the discriminant
function model. In contrast, the
stepwise- forward method selects
measures iteratively for inclusion
in the final discriminant function
model based upon their variance
contribution; only those measures
that best discriminate between
groups are included in the final
model.
Finally, correlation
analysis was performed, using the

Diagram 1: Measures Included in Multivariate
Analyses
39-Measure 19-Measure 32-Measure 15-Measure
FA
FA
DFA
DFA
OF
BB 1
BB 2
BB 3
BB Avg
STR 1
STR 2
STR Avg
YM-Alt 1
YM-Ent 1
YM-Alt 2
YM-Ent 2
YM-Alt Avg
YM-Ent Avg
EPC
EPO
EPT
WM Fin
WM Avg
WM RET 1
WM RET 2
WM RET 3
WM RET Avg
CPE Fin
CPE Avg
CPL Fin
CPL Avg
PR Fin
PR Avg
RAWM B4T1E
RAWM B4T4E
RAWM B4T5E
RAWM T4E
RAWM T5E
RAWM B4T1L
RAWM B4T4L
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Systat analytical software package, to determine whether a relationship exists between the
number of tau+ neurons in the brains of P301L mice and behavioral measures collected
from the same animals. Five measures of tau pathology (number of tau+ neurons in the
brainstem, cortex, hippocampus, amygdala, and whole brain) were used for this
correlation analysis with the same 39 behavioral measures used for factor analysis (see
Diagram 1)
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Results
Behavioral Effects of the rd Genotype
Table 1 shows the distribution of rd genotypes, by transgenic group, for all 32
animals in the study. Significant percentages of animals in all four groups were
determined to be homozygous recessive (rd/rd) for the retinal degeneration gene, with the
remaining animals being heterozygous (unaffected carriers) or normal. To determine the
effect of rd homozygosity and transgenicity on behavioral performance, behavioral
measures from all 32 animals were analyzed for main effects of rd homozygosity and
transgenicity, as well as for the interaction between the two. As summarized in Table 2, a
main effect of rd homozygosity was evident in multiple behavioral measures from most
cognitive-based tasks—particularly Morris water maze, platform recognition, and the
RAWM tasks. These effects of rd homozygosity on cognition were always deleterious in
impairing performance in tasks requiring good eyesight. By contrast, sensorimotor tasks
(e.g.: open field activity, balance beam, and string agility) were not affected by rd
homozygosity. Also unaffected were anxiety measures in the elevated plus maze and Ymaze spontaneous alternation, a cognitive-based task not reliant on good eyesight.
Given the wide-spread deleterious effects of rd homozygosity on performance in
multiple cognitive-based tasks/measures, data from all rd/rd mice (n=14) was eliminated
from the remainder of this study so that transgenicity effects could be unequivocally
evaluated. In addition, the one Tau+APP mouse that was not rd homozygous was
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Table 1: Distribution of wild-type (+/+), heterozygous (+/rd), and homozygous (rd/rd)
mice by Genotype
Genotype

Total

+/+ or +/rd

rd/rd

Non-Transgenic

11

7

4

Tau

10

7

3

APP

7

3

4

Tau+APP

4

1

3
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Table 2: Effects of rd homozygocity and genotype on behavioral performance
(P values indicated)

Balance Beam 1
Balance Beam 2
Balance Beam 3

0.41
0.10
0.14

Genotype
effect
0.18
<.01
0.02
0.01

String 1
String 2
Plus Maze (#CA)
Plus Maze (#OA)
Plus-Maze (time in OA)

0.65
0.91
0.77
0.51
0.30

0.98
0.78
0.73
0.34
0.29

0.41
0.47
0.50
0.04
<.01

Y-maze 1 (Entries)
Y-maze 2 (Entries)
Y-maze 1 (%-Alt)
Y-Maze 2 (%-Alt)

0.02
0.19
0.27
0.67

0.05
0.54
0.13
0.01

0.07
0.89
0.22
0.35

Morris Maze Avg. Acqusition
Morris Maze Acq. Final Day
Morris Maze Avg. Probe
Morris Maze Probe 1
Morris Maze Probe 2
Morris Maze Probe 3

<.01
0.01
0.01
0.05
0.05
0.10

0.28
0.29
0.16
0.01
0.75
0.57

0.24
0.24
0.20
0.92
0.66
0.16

Behavioral Measure
Open Field

rd/rd
effect
0.83

Interaction
0.28
0.94
0.87
0.52

Circular Platform Avg. Errors
0.48
0.30
0.62
0.04
Circular Platform Avg. Lat.
0.14
0.13
Platform Recognition Avg.
<.01
0.52
0.30
Platform Recognition Final Day <.01
0.22
0.66
RAWM Errors T1 Avg.
<.01
0.79
0.22
RAWM Errors T4 Avg.
0.01
<.01
0.58
RAWM Errors T5 Avg.
0.04
0.02
0.40
RAWM Latency T1 Avg.
0.01
0.28
0.53
0.01
0.04
RAWM Latency T4 Avg.
0.30
0.01
0.04
RAWM Latency T5 Avg.
0.15
#CA = # of closed arm choices
#OA = # of open arm choices
Note: Significant P values (<0.05) are highlighted in bold type and box shaded

53

comparable in behavioral performance to animals in the APP group on most tasks (except
circular platform and elevated plus maze); it was thus added to the APP group for
behavioral analysis of those tasks.

Effects of APP and Tau Transgenicity on Sensorimotor and Anxiety-based Tasks
In the balance beam task (Fig. 1), both APP and Tau transgenics were impaired at
5 months, while only the APP group was impaired in balance beam performance at 6.5
months. Overall, the APP transgenic group was impaired between 5 and 8.5 months
compared to Tg-, with a time x genotype interaction [F(4,30)=2.70; p<0.05]. For string
agility, no significant group differences were observed at either 5 months or 6.5 months,
although Tau transgenics approached impairment (p=0.065) at 6.5 months. Over both
time points, the Tau transgenic group was nearly impaired (p=0.07) compared to NT
mice (data not shown).
The 17- measure Neurologic Exam revealed no group differences, except that APP
transgenic mice had 1) a significantly depressed pelvis during locomotion compared to
both Tg- (p<0.0001) and Tau (p=0.022) groups, and 2) an abnormally hypotonic gait
compared to both Tg- (p=0.049) and Tau (p=0.049) groups (data not shown).
No group differences in activity/exploratory behavior were observed, as tested in
the open field at 5 months and the number of Y- maze entries at 5 months and 8.5 months
(data not shown).
In elevated plus maze testing, neither transgenic group exp ressed higher anxiety
that Tg- controls in any of the three measures analyzed (number of open arms entered, %
time in open arms, and number of closed arms entered) (data not shown).
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Balance Beam
NT
APP
Tau

70

Latency (sec)

60
50
40
30
20

*

*
**

*

10
0
5

6

7

8

Age (months)

9

NT APP Tau

Overall

Figure 1. A comparison of balance beam performance by age and
transgenicity (left) and overall (right) for APP and Tau transgenic mice
and NT control mice. Balance beam performance was measured by latency to fall from the b
apparatus over 3 successive trials. *p<0.05 compared to NT at that age (left)
or overall (right). **p<0.01 compared to NT at 5M.
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Although APP and Tau mice were found to be impaired in the balance beam,
performance in all other sensorimotor tasks (including those for visual acuity) and on the
anxiety task (with the exception of hypotonic gait and pelvic elevation in APP mice) were
normal. Thus, neither transgenic group has generalized sensorimotor dysfunction or
heightened anxiety that might significantly compromise performance in the cognitivebased tasks.

Effects of APP and Tau Transgenicity on Cognitive-based Tasks
For Y- maze % spontaneous alternation, Tg- and Tau mice improved their
performance between the 5- month and 8.5- month test points to about 70% alternation,
while APP mice performed at chance levels (~50%) at both ages (Fig. 2). Compared to
Tg- mice, APP mice were nearly impaired at 8.5 months (p=0.07) and significantly
impaired overall vs. Tg- mice (51.3±5.1% vs. 65.4±3.3%; p<0.05).
In Morris maze acquisition (Fig. 3), both Tg- and Tau mice nicely reduced their
escape latencies through the 9 days of testing. By contrast, APP mice showed no
improvement, being significantly impaired in comparison to both Tg- and Tau mice
across all 9 days of testing (p<0.05), and especially over the last block of 3 days
(p<0.007). Even on the final day of acquisition, APP mice continued to show
significantly higher latencies than Tg- mice (p<0.02). A genotype x day interaction was
also present [F(16,120)=2.55; p<0.005].
During Morris maze probe trials for memory retention, Tau mice performed
similar to Tg- mice in all three probe trials and overall (Fig. 4). However, APP mice were
impaired on the final probe trial (Day 10) compared to Tg- mice (p<0.05). Moreover,
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Figure 2. Y-maze percent alternation for APP and Tau transgenic
mice and NT controls at 5M and 8.5M. *p<0.05 compared to NT
overall.
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Figure 3. A comparison of Morris water maze escape latency between
APP and Tau transgenic mice and NT controls across 9 days of
acquisitional testing. *p<0.05 compared to NT and Tau mice over all
9 days of testing.
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Figure 4. Morris water maze retention performance for APP and Tau
transgenic mice and NT controls. Retention performance is measured as
percent time spent in the goal quadrant for each of the three retention
trials (left) and overall (right). *p<0.05 or compared to NT on day 10 (left)
and compared to NT and Tau mice overall (right).
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APP mice were impaired over all three probes in comparison to both Tg- and Tau
mice (p<0.02; Fig. 4). There were no differences in swim speed between the three groups
(data not shown).Over the eight days of circular platform testing, no significant genotype
effect was evident, with all three groups making a similar number of errors and having
similar escape latencies (data not shown).
Across the four days of platform recognition testing, Tau mice had escape
latencies comparable to Tg- controls (Fig. 5). By contrast, APP mice showed impaired
recognition abilities by having higher escape latencies overall compared to Tg- mice
(p<0.05); this impairment was particularly apparent during day 1 (vs. both Tg- and Tau
groups; p<0.05) and during day 3 (vs. Tg-; p<0.01). Nevertheless, none of the three
groups differed significantly on the final day of platform recognition testing.
Figure 6 presents the number of errors in RAWM working memory testing across
four 3-day blocks for Trial 1 (randomized initial trial), Trial 4 (final acquisition trial), and
Trial 5 (delayed retention trial). Tau mice performed similar to Tg- mice, although they
made almost significantly more T4 errors vs. Tg- mice during the critical last block of
testing (p=0.06). Compared to both Tg- controls and Tau transgenic mice, APP mice
made significantly more working memory errors in Trial 4 of block 2, as well as in Trial
5 during the last three blocks of testing. The T5 impairment of APP mice was so
prevalent that a strong genotype x blocks interaction was present [F(6,42)=3.70;
p<0.005].
The impaired RAWM performance of APP mice is further underscored when
errors are averaged over all four blocks of testing (Fig. 7). APP mice made significantly
more T4 errors overall than Tg- controls (p<0.02) and more T5 errors overall than both
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Figure 5. A comparision of platform recognition latency
between APP andTau transgenic mice and NT controls
across four days of testing. ** p<0.05 or higher level of
significance compared to NT and Tau on day 1 of testing.
* p<0.05 or higher level of significance compared to NT
on day 3 of testing.
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Figure 6. Radial-arm water maze errors for APP and Tau transgenic mice and NT
control mice across four 3-day blocks of testing for T1, T4, and T5. *p<0.05 or
higher level of significance compared to both NT and Tau mice for that particular
block and trial.
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Figure 7. A comparison of radial-arm water maze errors
for T1, T4, and T5 in APP and Tau transgenic mice and
NT controls across 12 days of testing. *p<0.05 compared
to NT controls. **p<0.01 compared to NT and Tau mice.
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Tg- and Tau mice (p<0.01). APP mice were unable to improve their overall working
memory performance from T1 through T5 (Fig. 7), whereas both Tg- and Tau mice were
able to substantially reduce their number of errors over the same overall trials. Statistical
evaluation of RAWM latency measures revealed very similar results to those obtained by
analysis of RAWM errors (data not shown.)

Factor Analysis
Factor analysis of behavioral measures was performed to determine the
underlying relationships between tasks. Table 3 indicates the task/measure loadings when
all 39 behavioral measures were included in the analysis. Five principle factors were
obtained. Measures for RAWM, platform recognition, and Morris maze acquisition
loaded heavily under Factor 1, which accounted for more variance (25.2%) than any
other factor. This factor encompassed multiple cognitive domains, including working
memory, recognition, and reference learning. Morris maze memory retention loaded
independently on Factor 5, indicating an independent loading of reference memory
separate from other cognitive domains. Measures from two other cognitive-based tasks,
circular platform and Y-maze spontaneous alternation, also loaded on factors separate
from Factor 1. Factor 2 loaded balance beam and string agility measures, indicating this
factor’s sensorimotor basis, specifically involving balance/agility.
Similar factor loadings were obtained when a subset of 19 measures was used in
the factor analysis (Table 3). The 19- measure subset (which omits all intermediate
measures, redundant RAWM latency measures, and elevated plus maze measures) has
been used routinely in our prior studies (Leighty et al., 2002). For the six primary factors
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Table 3: Task loadings resulting from 39- and 19- measure factor analysis involving
all rd- animals (n=18)

Factor

39 Measures

19 Measures

I

(25.2)
RAWM working memory
Platform Recognition
Morris Maze acquisition

(25.0)
RAWM working memory
Platform Recognition
Morris Maze acquisition

II

(16.1)
Balance Beam
String Agility

(16.4)
Circular platform
(errors and latency)

III

(13.8)
Y-maze (% Alt. and entries)
Circular platform (errors)

(15.8)
Open Field activity

IV

(10.1)
Circular platform (latency)
Elevated Plus-Maze (O.A.)

(9.5)
Balance Beam

V

(7.6)
Morris Maze retention

(7.9)
String Agility

---------

(6.8)
Morris Maze retention

VI

O.A. = # of open arm entries and time spent in open arms
Numbers in parentheses are percent of total variance explained
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obtained, Factor 1 was again heavily based on cognitive domains provided by measures
in the RAWM, platform recognition, and Morris maze tasks. Also consistent with the 39measure analysis, Morris maze reference memory and circular platform measures loaded
independently and separate from the primary cognitive factor (Factor 1). However,
balance and agility measures had separate loadings for the 19- measure data set.

Discriminant Function Analysis (DFA)
To determine whether the behavioral performance of the three groups (NT, Tau,
and APP) could be used to distinguished them from one another, Discriminant Function
Analysis (DFA) was performed (Table 4). The same behavioral measures were included
as for Factor Analysis, except that the four circular platform and three elevated plus maze
measures were omitted.* For the resulting 32- and 15- measure data sets, the direct entry
DFA method (which includes all measures) could not discriminate between the three
groups based on their behavior. In sharp contrast, the step-wise forward DFA method
(which selects measures based on their contribution to variance) was highly effective in
completely discriminating between all three groups using either 32- or 15-measure data
sets (Table 4). For both step-wise forward DFA analyses, 8 measures provided maximal
discriminablilty. These distinguishing measures were mostly cognitive-based, being taken
from RAWM, Morris maze, and platform recognition tasks. Thus, these tasks are
particularly important, and sufficient, to behaviorally distinguish between all three
groups.
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Table 4: 15- and 32-measure discriminant function analysis of Tg-, APP, and Tau groups
Measures

15

32

Direct Entry Method
(All measures used)

Not Discriminable

Not Discriminable

Step-wise Forward Method
Significance
Measures Used

p<.0001*

RAWM B4T4 errors
RAWM T5 errors (average)
Morris Maze acquisition (Final Day)
Morris Maze retention (average)
Platform Recognition (Final Day)
Platform Recognition (average)
Balance Beam
String Agility (average)

p<.0005*

RAWM B4T4 errors
RAWM T5 latency (average)
Morris Maze retention (Day 7)
Platform Recognition (Final Day)
Platform Recognition (average)
Balance Beam
String Agility (average)
Open Field

*Significant p values are for Wilks' lambda, designating overall discrimination between the 3 groups
(Tg-, APP, and Tau). Post-hoc pair-wise comparisons were all significant at p<0.05 or greater level of
significance, thus providing complete discrimination between the two groups.
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*These two tasks were omitted because behavioral scores of the single APP+Tau mouse
included in the APP group were not cons istent with other APP animals in the these two
tasks. Omission of this animal’s data from these two tasks would have eliminated all of
that animal’s data from the other tasks for DFA. As well, neither task showed genotypic
differences in performance.

Correlations Between Cognitive Performance and Tau Pathology
For the Tau transgenic group alone (n=7), a number of significant correlations
were found between cognitive performance in the three water-based tasks and the number
of Tau+ neurons in the neocortex and hippocampus (Table 5). Escape latencies during the
final day of Morris maze acquisition and in both platform recognition measures were
highly correlated with Tau+ neurons numbers in neocortex. Thus, poorer performance in
both tasks correlated with increased number of Tau+ neurons. Moreover, RAWM T5
errors in the final block and overall T5 latency, as well as overall platform recognition
latency, correlated with Tau+ neurons in hippocampus. Thus, poorer working memory
(RAWM) and recognition correlated with increased numbers of Tau+ hippocampus
neurons. Three examples of these correlations are depicted in Figure 8.
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Table 5: Correlations between number of Tau+ neurons and cognitive performance in Tau
transgenic mice (N=7) ("p" values indicated for significant correlations)
Behavioral Measure

Tau+ Neurons Tau+ Neurons
Tau+ Neurons
in Neocortex in Hippocampus in Whole Brain

Morris Maze Latency (Last day)

0.016

n.s.

0.025

Platform Recognition Latency (overall)

0.000

0.013

0.000

Platform Recognition Latency (Last day)

0.007

n.s.

0.012

RAWM errors (Last Block, T5)

n.s.

0.036

n.s.

RAWM latency (T5 average)

n.s.

0.022

n.s.
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Correlations Between Number of Tau+ Neurons
and Cognitive Deficits in P301L Mice
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Figure 8. Graphs indicating the significant
correlations between number of tau+ neurons in
cerebral cortex and hippocampus of P301L
mouse brains and cognitive behavior measures
in the three water-based tasks. Significant r
values and p values for the correlations are listed.
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Discussion

General Summary
The results of this study indicate that retinal degeneration seriously impairs the
performance of mice in behavioral tasks requiring good vision. Animals that carry the
homozygous allele of this mutation must, therefore, be eliminated from any such study
requiring visual acuity. Young APP mice were found to be impaired in several cognitive
tasks, including platform recognition, Morris maze, and Y-maze, as early as 5.5 months
of age. These mice were, however, found to have fairly normal sensorimotor function,
demonstrating significant impairment only in balance beam performance starting at 5
months. P301L mutant tau mice were not found to possess significant impairments in any
sensorimotor or cognitive tasks through 8.5 months of age. Factor analysis was
successfully able to group those behavioral measures that shared the most in common and
contributed the most variance to the behavioral data. Likewise, discriminant function
analysis (DFA) was able to accurately discriminate between the three transgenic groups
of mice using only an 8-measure data set. Finally, the use of correlation analysis
demonstrated an association between the formation of NFT’s in cortex and hippocampus
and cognitive impairments in P301L mice.

71

Effects of Retinal Degeneration
Through the use of genotyping, it was determined that most of the 32 animals
selected for this study were either unaffected carriers (rd/+) of the rd gene or homozygous
recessive (rd/rd), predisposed to developing retinal degeneration. A significant number of
animals from each transgenic line were (rd/rd) and thus suffered from retinal
degeneration. To determine the extent to which retinal degeneration played a part in the
behavioral impairment of these animals, all subjects’ behavioral scores were assessed
using both genotype and rd status as independent grouping variables. Performance in
several behavioral tasks, including Morris water maze, platform recognition, and radialarm water maze, were negatively affected by retinal degeneration. These findings
illustrate that poor vision, caused in this case by the retinal degeneration (rd) gene,
significantly impairs behavioral performance in those tasks that require keen vision.
Performance in sensorimotor tasks, such as balance beam, string agility, and open field,
which require less visual acuity, failed to demo nstrate any significant correlation with
retinal degeneration. Spatial acquisition tasks, such as Morris water maze, platform
recognition, and RAWM, which require visual acuity, demonstrated the most significant
impairments due to the rd gene. These findings agree with the results obtained by
Spencer et al. (1995), indicating that retinally-degenerate aged rats, albeit not caused by a
genetic mutation, had behavioral impairment in the Morris water maze (a spatial
acquisition task). A study conducted by Fuller et al. (1973) found, however, that rd/rd
mice showed no impairment in a spatial water T-maze that required that test subjects
locate an escape ladder found in one of the two swim arms. The authors suggest that
these results may be an indication that spatial cues are not a significant component of
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learning in this task. These results are in agreement with our findings that the rd mutation
does not significantly affect performance in the Y-maze spontaneous alternation task, a
similar task that requires cognitive function with limited visual acuity. Curiously, my
findings contradict the results obtained by Cook et al. (2001), who reported that rd/rd
mice show less anxiety when placed in an elevated zero maze, preferring to spend more
time in the open arms of the maze than the closed arms. My findings indicate no
significant difference between rd/rd mice and mice with normal vision (+/+ and rd/+) in
the amount of time spent in the open arms or the number of open arm entries made in the
elevated plus maze, a similar task used to measure anxiety.
Because rd/rd test subjects were found to have significant impairments in various
tasks, irrespective of transgenicity, all such animals were excluded from further statistical
analysis. The elimination of these rd/rd mice reduced the number of experimental animals
from 32 to 18: 7 Tg- mice, 7 Tau mice, 3 APP mice, and only a single Tau+APP mouse.
The performance of the single TAPP mouse did not significantly differ from the
performance of the remaining three APP mice in all tasks except circular platform and
elevated plus maze, therefore it was grouped with the APP mice for the purposes of
statistical analyses.

Effects of APP and Tau Transgenicity on Sensorimotor and Anxiety-Based Tasks
To assess levels of anxiety and sensorimotor function in transgenic and nontransgenic mice, all test subjects were evaluated in a variety of tasks. According to my
findings, neither of the two transgenic groups showed differences in exploratory behavior
compared to Tg-, as measured by activity in the open field task and the number of entries
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made in the Y- maze spontaneous alternation task. These observations are in agreement
with the findings put forth by Holcomb et al., (1999), indicating that APP mice are not
significantly different from Tg- in their number of Y- maze entries at 6 and 9 months.
King and Arendash (2002a) reported that APP mice are more active in the open field,
compared to Tg-, at 3 months of age, but not at 9 months. My findings, which involve an
intermediate time point, indicate that APP mice are not more active in the open field at 5
months compared to Tg-.
Both transgenic lines did, however, experience some impairment in the balance
beam and string agility tasks. When evaluated at 5 months of age, both the APP and Tau
groups had significant impairment in the balance beam when compared to Tg-, while
only the APP mice exhibited similar impairments when the animals were re-tested at 6.5
months of age. Neither transgenic group showed impairments at the final time point of
8.5 months. Overall, the APP mice were significantly impaired in their balance beam
performance when compared to Tg-, while the performance of the Tau mice was not
significantly different from control. While neither transgenic group had statistically
significant deficits in string agility, the Tau group did exhibit nearly-significant
impairments in string agility at 6.5 months of age (p=0.065) and overall (p=0.07),
compared to Tg-. King and Arendash (2002a) agree with my observation that APP mice
are impaired in the balance beam at an early age. The authors found that APP mice are
impaired in balance beam at 3, 14, and 19 months of age, but not at 9 months, while my
observations indicate that APP mice are impaired at 5 and 6.5 months of age, but not at
8.5 months. In addition, King and Arendash (2002a) indicate that APPsw and Tg- mice
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are not significantly different in string agility at 3 and 9 months of age, which agrees with
my observation that APP mice are not impaired in string agility at 5 or 6.5 months of age.
Neither group experienced heightened anxiety as evidenced by the fact that both
the APP and Tau groups spent similar amounts of time in the open arms of the elevated
plus maze and made a similar number of open arm choices compared to Tg-.
Finally, the 17-Measure neurologic screen revealed that APP mice suffered from a
mild hypotonic gait and slightly depressed pelvis. Neither of these conditions, however,
precluded the APP mice from performing in any of the behavioral tasks.
While little is known regarding the behavioral impairments associated with
mutations to the tau protein that lead to NFT formation, there are a few significant
findings that relate to the observations made in this paper. Lewis et al., (2000) report that
P301L mice display severe sensorimotor deficits as early as 4.5 months of age in
homozygous animals and beginning at 6.5 months in hemizygotes. These deficits include
the lack of an escape extension during tail elevation, spontaneous back paw clenching
while standing, a delayed righting response, an inability to hang from a suspended string
for more than a few seconds, and decreased grooming, weight, and mobility. While my
study did not address such variables as body weight and grooming, the observations made
during an extensive array of sensorimotor tasks reflect the relatively normal function of
all Tau mice through the 5 to 8.5 month test period. As discussed previously, all Tau
mice in this study displayed normal ambulation and activity, as well as proper
sensorimotor function and neurological response to stimulation. Moreover, Tau mice, as a
group, performed similar to Tg- controls on all behavioral measures analyzed during the
test period. Tanemura et al., (2002) reported that V337M mice, which form hippocampal
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NFT’s as early as 11 months, show increased locomotion in the open field tasks and
elevated plus maze and spent more time in the open arms of the elevated plus maze at 11
months of age. While these observations involve a different transgenic line and different
age group from the animals used in my study, they still form a critical basis for
comparison. As discussed earlier, the P301L mice evaluated in my study showed no
differences in their level of activity or anxiety compared to Tg-. It must be noted,
however, that the V337M mutation results in more extensive NFT formation and less
profound cell death than the P301L mutation. Additionally, the V337M transgenic line
produces NFT’s almost exclusively in the hippocampal region, unlike the P301L line,
which generates abnormal tau in the hindbrain and brain stem as well as the
hippocampus, predisposing the animal to potential sensorimotor deficits. Tatebayashi et
al., (2002) observed sensorimotor and cognitive function in 16-23 month-old R406W tau
mutant mice, a transgenic line that produces forebrain NFT’s beginning at approximately
18 months. In the study, Tatebayashi et al. observed that these mice display normal
physical characteristics, sensorimotor reflexes, and motor coordination, compared to Tg-.
These findings, albeit based on a different line of tau mutant at a different age, is in
agreement with the results obtained in my study.

Effects of APP and Tau Transgenicity on Cognitive-based Tasks
To determine the cognitive deficits associated with the APPsw and P301L
transgenic lines, transgenic and non-transgenic mice were evaluated in a variety of
cognitive-based tasks. In Y- maze percent spontaneous alternation, APP mice were very
nearly impaired (p=0.07) vs. Tg-, in their ability to spontaneously alternate between the
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three arms of the maze at 8.5 months of age. Overall, the APP group was impaired,
compared to Tg-, in the percent alternation task, while Tau mice show no significant
deficits in this task. A study by Hsaio et al. (1996) indicate that APP mice are unimpaired
at 3 months of age in Y- maze spontaneous alternation, but develop impairments at 10
months of age. These results agree with the findings from my study, indicating that APP
mice are nearly impaired at 5 and 8.5 months of age and impaired overall for both time
points. Also consistent with my findings, Holcomb et al., (1999) studied the performance
of APP mice in the Y- maze spontaneous alternation task and found that they develop
significant impairments at 6 months. A study performed by King and Arendash (2002a)
revealed that APP mice develop deficits in Y-maze alternation as early as 3 months of
age, but not at 9 months of age. King and Arendash do, however, report an overall Ymaze impairment from 3 to 19 months of age.
The Morris water maze acquisition test, which requires that mice learn the
location of a static, submerged platform over a period of nine days, also revealed
cognitive deficits in the APP group. In this task, the APP mice had a significantly longer
latency, compared to Tg- and Tau, to locate the hidden platform on the final day of
acquisition (day 9), as well as overall. Tau mice showed no impairments in locating the
platform. The memory retention phase of this task (which occurred prior to acquisition
testing on days 4 and 7, and following the last day of acquisition on day 10) evaluated
mice on their ability to search for the escape platform after the platform had been
removed from the pool. Animals that spend the most time in the goal quadrant, which
formerly contained the escape platform, are said to demonstrate superior memory
retention. While both transgenic groups performed similarly to Tg- on days 4 and 7, the

77

APP mice demonstrated a significant impairment in memory retention in the final
retention trial (day 10) compared to Tg-. In addition, APP mice also exhibited an overall
impairment in memory retention compared to Tau and Tg- groups across all three
retention trials. These acquisition and retention impairments in APP mice cannot be
explained by each mouse’s swim agility, as all groups of mice were found to swim at
approximately the same speed when placed in the pool. Hsaio et al., (1996) found that
Tg2576 mice show no impairments in Morris water maze acquisition or retention at 2 or
6 months of age, but begin to exhibit such impairments at 9-10 months. The results of my
study indicate that APP mice are, in fact, impaired in Morris water maze acquisition and
retention as early as 5.5 months of age. It must be noted, however, that Hsaio et al.
employed APPsw mice with a Tg2576 background, while my study involved APPsw
mice with a more mixed strain background. Further, Westerman et al. (2002) conclude
that Tg2576 mice develop impairments in Morris water maze acquisition and retention
beginning at 6 to 11 months. In contrast, Koistinaho et al. (2001) report that APP mice
are impaired in Morris water maze much earlier--as early as 3 months of age. In their
comprehensive behavioral study of APP mice, King and Arendash (2002a) find that Tg+
mice possess no performance deficits in water maze acquisition and retention through 19
months of age, compared to Tg-.
APP mice were also found to be impaired in the platform recognition task,
requiring animals to swim to a clearly visible, raised platform, whose location changes
throughout the four trials of daily testing. Overall, APP mice required a significantly
greater amount of time to locate and mount the visible platform than Tg-. Specifically,
the APP mice performed worse in the platform recognition task than either Tau or Tg-
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mice on the first day of testing, and demonstrated longer latencies on day 3, compared to
Tg- only. Curiously, the APP group of mice did not demonstrate an impairment to locate
the platform on the final day of testing, often described as the best indicator of task
performance. This result may be an indication that APP mice are slow in their ability to
change their search strategy. Unlike the Morris water maze, which requires that mice
memorize the spatial location of a fixed hidden platform, the platform recognition task
demands that mice be able to track the changing locations of a visible platform in the
same pool. Tau mice were not significantly impaired compared to Tg- in this task. King
and Arendash (2002a) found that Tg2576 mice are impaired in the platform recognition
task at 9 months and beyond. My data indicates that impairment in platform recognition
occurs much sooner in APP mice, as early as 6 months of age.
The radial-arm water maze (RAWM) was also used to assess cognitive function in
this study. RAWM is a sensitive task that assesses working memory. In daily testing,
working memory is most evident on the last of the four successive acquisition trials (T4)
and the delayed retention trial (T5), which occurs 30 minutes after completion of trial 4.
Unlike the Morris water maze, where the location of the platform remains constant
throughout the nine days of testing, the RAWM task employs a semi-random sequence to
rotate the platform between each of the six swim arms for each day of testing. This
unique facet of the RAWM task is what requires the use of working memory. The
RAWM task also requires spatial reference of external cues, as does the Morris water
maze, to locate the hidden platform. When mice were evaluated across the 12 days of
testing, APP mice were found to exhibit an “overall” impairment on T4 and T5 in
locating the hidden platform, compared to Tg-, indicating working memory impairment.
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When the 12 days of RAWM testing were analyzed separately in four 3-day blocks, APP
mice were found to make more errors than Tg- and Tau in T5 for blocks 2, 3, and 4, as
well as T4 in block 2. APP and Tau mice were also nearly impaired vs Tg- in T4 for
block 4. Although not reported here, similar results were obtained for RAWM latency.
Despite the wealth of information concerning the cognitive impairments of APP mice,
there is no published data describing the performance of these mice in radial-arm water
maze. A study by Arendash et al. (2001) did, however, describe the performance of
APPsw+PS-1 mice in the radial-arm water maze task at both 5-7 and 15-17 months of
age. The study found that these mice showed no impairments in T4 performance at either
time point but did display impairments in T5 at 15-17 months.
Finally, circular platform, a cognitive task that incorporates stress and anxiety,
revealed no significant impairments for either transgenic group compared to Tg-. King
and Arendash (2002a) are in agreement with my results concerning the circular platform
task, concluding that APP mice are unimpaired in this task through 19 months of age.
Currently, very little is known with regards to the cognitive impairments incurred
by mutations to the tau protein. Tanemura et al. (2001) do report, however, that V337M
tau mutants are unimpaired in the Morris water maze at 11 months of age. These results
are in agreement with the findings described in my study, indicating that P301L tau mice,
as a group, are unimpaired in all cognitive tasks. A study by Tatebayashi et al. (2002)
found that R406W tau mutants are impaired in the contextual and cued fear condition
tasks, measures of associative memory. Thus far, this is the only published evidence that
any mutation to tau is capable of generating cognitive impairments in animal models of
Alzheimer’s disease.
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Factor Analysis
Factor analysis is a very powerful tool used in statistics that has the ability to
evaluate a large data set, determine which measures contribute the most variance to the
data set, and what the underlying relationship is between these measures. In this study,
factor analysis was used to group all 39 behavioral measures into common factors, each
contributing to the variance of the behavioral data set. Each factor contains behavioral
measures that are related to one another. Behavioral measures that are grouped into the
same factor are therefore assessing a similar component of behavior (i.e.: sensorimotor
function, working memory, etc.). Through the use of factor analysis, we can infer the
relationship between multiple tasks, and predict how performance in one task might be
predictive of performance in another task. In this study, two separate factor analyses were
performed, one using the entire 39- measure data set, the second using a more selective
19-measure data set. The results of the factor analysis indicate that the RAWM working
memory task, platform recognition task, and Morris water maze acquisition task share a
lot in common, as they all load together under factor 1. These three tasks each serve as
indicators of unique aspects of cognitive function, including working memory,
recognition, and reference learning. Balance beam and string agility also loaded together,
under factor 2 for the 39- measure analysis, illustrating how these two tasks both serve as
measures of balance and agility. Y- maze spontaneous alternation and circular platform
also loaded together (factor 3 of the 39- measure analysis), underscoring the cognitivebased properties of these two tasks. In each analysis, Morris maze retention loaded
independently, indicating the unique nature of reference memory from all other cognitive
measures.
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While factor analysis is a fairly common statistical tool in various scientific and
mathematical fields, it is still a novel concept in the realm of behavioral analysis. As
such, there is little precedent for this type of ana lysis in Alzheimer’s transgenics. While
King et al. (1999) were the first to utilize factor analysis to determine which behavioral
measures relate to one another, the factor analysis employed in their study was “rotated”
and only task (not measure) loadings were reported. Based on my findings, therefore, I
believe that factor analysis has the potential to further explain the complex relationships
between the tasks currently used to evaluate sensorimotor and cognitive function in
transgenic mice.

Discriminant Function Analysis
Like factor analysis, discriminant function analysis (DFA) is a powerful statistical
tool that has recent ly been introduced into behavioral analysis. DFA works by evaluating
multiple data sets to determine whether the data sets can be discriminated from one
another and which measures are best able to distinguish them. In this study, DFA was
used to evaluate the behavioral data from the three groups analyzed (Tg-, APP, and Tau)
to determine whether they could be completely discriminated and, if so, which behavioral
measures can best discriminate between the three groups. Two DFA methods were used
in this study, the direct-entry method and the stepwise- forward method. In addition, for
each method, two separate analyses were run, one with the entire dataset, and the other
with only 15 behavioral measures. The direct entry method utilizes all behavioral
measures in the DFA model, while the stepwise- forward method selects measures one at
a time, keeping only those variables that are best able to discriminate between the three
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groups in the final model. The results of the DFA analysis indicate that the direct entry
method was unable to discriminate between the three transgenic groups. The stepwise
forward method, however, was able to discriminate between the three groups using only
eight behavioral measures. The 15- and 32- measure stepwise DFA models each arrived at
a set of eight measures, with both sets having most of these behavioral measures in
common. In both analyses, cognitive measures, including RAWM working memory,
Morris water maze, and platform recognition, were found to be critical in discriminating
between the three groups. Certain sensorimotor tasks, such as open field activity, balance
beam, and string agility, were also found to be important in discriminating between Tg-,
Tau and APP groups.
DFA, like factor analysis, is still a very new concept in beha vioral analysis and, as
a result, has no precedent in Alzheimer’s transgenics. Like factor analysis, however, DFA
appears to hold great promise for inclusion in future behavioral studies. DFA has the
potential to eliminate the need for large behavioral test batteries, instead selecting a small
subset of behavioral measures that are equally capable of discriminating between various
transgenic groups. In this way, less time and effort would be needed to accurately
evaluate the sensorimotor and cognitive function of transgenic mice and the effects of
therapeutics therein. Before DFA can be used with great accuracy in a wide variety of
behavioral studies, however, it must be studied further to determine how its precision
holds up with different transgenic lines and various age groups. In the future, DFA may
be instrumental in the development of better behavioral test batteries.
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Correlations Between Behavioral Performance and Tau Pathology
In order to create a link between the biochemical and pathological changes that
take place in the brains of tau mutant mice with their associated sensorimotor and
cognitive deficits, a correlational analysis was performed. In the analysis, five measures
of tau pathology were used as biochemical markers: number of tau+ neurons in the
brainstem, cortex, hippocampus, amygdala, and whole brain. These five pathological
measures were entered into a correlational matrix with the 39 behavioral measures
discussed previously. The results of the analysis indicate that tau pathology is exclusively
correlated with deficits in cognitive function, particularly in the swimming tasks. An
increased number of tau+ neurons in the whole brains of P301L mice was found to be
correlated with impaired performance on the final day of Morris maze acquisition and
platform recognition, as well as overall performance in platform recognition. When the
number of cortical tau+ neurons was correlated with behavioral impairments, these same
relationships were seen, indicating the critical nature of the cortex in cognitive function.
The amount of hippocampal tau was found to be correlated with performance in the
platform recognition and radial-arm water maze tasks, specifically T5 errors in the final
block of testing and overall T5 latency, two measures of working memory. This finding
seems to illustrate the function of the hippocampus in working memory and spatial
acquisition. There were no significant correlations between behavioral performance and
tau pathology in the brainstem and amygdala, indicating the relative unimportance of
these two brain regions in cognitive function. While brainstem tauopathy has been linked
to sensorimotor deficits in other Tau studies, the relative lack of any such correlation in
this study, coupled with the absence of any significant sensorimotor deficits, indicates
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that tauopathy present in the brainstem during the behavioral testing period was not
detrimental to cognitive or sensorimotor performance.
As discussed previously, there are only a small number of studies that have
attempted to characterize the behavioral impairments associated with tau mutations. Of
the few studies that have been carried out, none of these has utilized a comprehensive test
battery to assess sensorimotor and cognitive deficits. As a result, there is no precedent for
the type of correlational analysis that is described in this study. Based on these findings,
however, we can conclude that a strong correlation exists between the formation of
NFT’s in the hippocampus/cortex and behavioral impairment. The fact that the P301L
mice observed in this study failed to show any significant cognitive or sensorimotor
impairments between 5 and 8.5 months of age illustrates that these mice, as a group, did
not develop extensive enough NFT formations during the age range eva luated to generate
such impairments in all mice. However, NFT formation in individual animals (those
further along in forebrain tauopathy), was associated with, and likely causative to,
cognitive impairment in three tasks. Unfortunately, the presence of extensive NFT’s in
the hindbrain and brainstem of these P301L mice results in premature hind limb paralysis
and death, precluding the assessment of behavioral impairment in these mice beyond 9
months. If such an evaluation were possible, however, it would be expected that P301L
mice, as a group, would become significantly impaired in cognitive tasks beyond 9
months of age, corresponding with an increase in the number of cortical and hippocampal
NFT’s.
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In summary, the results of this study indicate that APP mice are cognitivelyimpaired at a young age, as early as 5.5 months old, while appearing to be largely devoid
of any debilitating sensorimotor deficits through the same time frame. Conversely, tau
(P301L) mutants are found to have no significant sensorimotor or cognitive impairments
through 8.5 months of age.
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